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Abstract
Cell-based bone tissue engineering has shown encouraging results in animal models and
even a few human patients. This method could supplement or replace autologous
(patient-derived) bone as a bone grafting material, with less damage to existing bone.
However the factors that lead to the successful healing of bone injuries by cell-based
tissue engineering are poorly understood and the optimal biomaterial for this task has not
yet been identified. This dissertation will present: (i) the development of a live animal
imaging model to visualize the healing process in a tissue engineered implant for bone
regeneration and the novel observations found therein, (ii) the development of a sterile
collagen-hydroxyapatite scaffold for consistent bone formation in vivo, (iii) the
comparison of different methods of cell delivery to collagen-HA scaffolds in the context
of bone formation in vivo, and (iv) the development of a novel porogen method to
enhance the permeability of collagen-HA scaffolds and the usefulness of permeability as
a scaffold design metric indicative of success or failure in vivo. These results have
deepened our understanding of cell-based bone tissue engineering, biomaterial fabrication,
and biomaterial design, and should improve the efficacy and consistency of cell-based
bone tissue engineering.
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1 Introduction

1.1 The Structure of Bone
Bone is an extraordinary biological composite composed of stiff ceramic and flexible
protein filled with vasculature, nerves, and a variety of specialized cells. Hydroxyapatite
nanocrystals are organized hierarchically within collagen fibers and other proteins, which
provide bone with excellent mechanical properties compared with its constituents alone.
On the macroscale, dense cortical bone forms the diaphysis while more porous cancellous
bone is present at the distal and proximal ends (Figure 1-1). The trabecular architecture of
cancellous bone is aligned with lines of compression and tension, noted as early as 1870
by Wolff, to further enhance to the mechanical integrity of bone.1 Human cortical bone
contains longitudinal cylinders of layered mineralized collagen arrays known as osteons,
each with a central void known as a haversian canal, which contains nerves and blood
vessels (Figure1-2). The dense cortical bone also contains cells (osteocytes) embedded in
void spaces called lacunae, which are interconnected by smaller canals know as
canaliculi. Osteocytes are thought to act as a sensor network in cortical bone, regulating
bone remodeling through mechanotransduction.2 The collagen fiber arrays that form the
osteon are aligned at different angles from layer to layer. This is thought to introduce
isotropy which improves the compressive strength along many directions.3
Macromolecular collagen fibers contain arrays of individual triple helical collagen
molecules (fibrils) joined by hydroxyapatite nanocrystals at their terminal ends. The
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mineralized collagen fiber is one of the most abundant biomineralization templates found
in nature (teeth, bone, and antlers) and is highly conserved throughout the animal
kingdom.

Figure 1-1 | Cortical and cancellous bone architecture as seen by Wolff. Line drawing
at right indicates trabecular alignment with directions of compressive and tensile forces.
Photographs from [1].
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Figure 1-2 | The osteon, haversian sytem, and osteocyte network of cortical bone.
Inset at top right shows the osteocyte network of lacunae and canalculi within cortical
bone. Cylidrical template of the osteon is shown with haversian canals filled with blood
and lymphatic vessels. Bottom right highlights the periosteal layer of cells that surrounds
the exterior of the bone. From Taylor et al.4
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Figure 1-3 | The hierarchal structure of mineralized collagen fibers in bone. From
left to right: the collagen triple helix, mineralized collagen fibrils, layered plywood-like
structure with alternating direction of the osteon, and cross section of the cortical bone
showing osteons. From Meyers et al.5

1.2 The Composition of Bone
The bone matrix is primarily composed of hydroxyapatite (~69% by weight) substituted
with ions such as carbonate, fluoride, magnesium, and other trace elements depending on
diet.6,7 Type I collagen forms ~90% of the organic fraction of bone, with the remaining
~10% being proteins such as osteonectin, fibronectin, and osteopontin, among many
others.6 Bone also contains ~10% water by weight, primarily associated with collagen in
the bone where it helps maintain its structure.
1.2.1

Hydroxyapatite - Ca5(PO4)3(OH)

The crystal structure of hydroxyapatite (HA) is shown in Figure 1-4. HA crystallizes as
either a monoclinic or hexagonal unit cell, with the hexagonal form being much more
common.8–11 The dimensions of the hexagonal unit cell are a = 9.43 Å and c = 6.88 Å.
The crystal structure contains two distinguishing features. First, the hydroxyl groups are
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stacked along the c-axis, forming columns of ions spanning the crystal. Oxygen,
phosphorus, and calcium ions surround the hydroxyl groups to form a column along the
c-axis (Figure 1-4B, grey circle). Secondly the four oxygen atoms adjacent to the
phosphorus atoms form tetrahedrons (Figure 1-4A). The closest bond length (0.9 Å) is
found in the hydroxyl groups on the c-axis. Shorter bonds are generally stronger as a
result of more participating electrons. The hydroxyl group oxygen is bonded at distance
of about 3 Å. The long bond length between the hydroxyl group and surrounding atoms is
easily distinguished (Figure 1-4B, grey circle) by the amount of open space in the
structure. As a result, the hydroxyl groups are more weakly bound to the structure.

Figure 1-4 | Crystal structure of hydroxyapatite. (A) 3D structure of HA showing
phosphate tetrahedrons and hydroxyl groups aligned along the c-axis projected in 2D
along the c-axis. (B) Black and white drawing from Kay et al. superimposed by a 3D
rendering in the same orientation to show the agreement with description by symmetry
and atom positions. Columns (grey circle) of hydroxyl groups surrounded by oxygen and
phosphate atoms are oriented in the c-direction.
1.2.2

Collagen

Collagens, of which there are twenty-eight types and many other proteins with collagenlike domains, are the most abundant protein found in the animal kingdom.12 Type I
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collagen, present in bone, tendon, and other connective tissues is the most abundant
collagen protein. The primary structure of collagen consists of the amino acid triplet
XaaYaaGly, where Glycine is repeated every third residue, and Xaa and Yaa can be any
amino acid. Most frequently the Xaa and Yaa positions are occupied by Proline and
Hydroxyproline, respectively (Figure 1-5A). The secondary structure of type I collagen is
the α-helix, composed of repeating tripeptide units. The C- and N- terminus of the
tripeptide chains contain telopeptide elements, which have a net negative and positive
charge, respectively.13 The COL1A1 and COL1A2 genes produces pro-collagen α-helix
molecules that, following post-translational modification of the telopeptide ends, form the
triple helical collagen monomer (tropocollagen) consisting of one α2 chain and two α1
chains (Figure 1-5B).14 The triple helix is bound together by a single interstrand hydrogen
bond between each amino acid triplet (Figure 1-6). Mutations in COL1A1 or COL1A2
that disrupt the triple helical structure can result in disease states such as Osteogenesis
Imperfecta and Ehlers-Danlos syndrome, among others.12

Tropocollagen monomers can self-assemble into large, organized fibers with a so-called
D-periodicity of 67 nm. This pattern is caused by the repeating gap between subsequent
monomers (Figure 1-5C). To link collagen molecules within the fiber, the telopeptide
regions of each tropocollagen molecule can be cross-linked via Lys side chains. Crosslinking of this kind is enzymatically formed by lysyl oxidase. Absence of telopeptide
regions does not prevent fibril formation, however fibrils lacking these crosslinks are
weaker and individuals with mutations interfering with tropocollagen crosslinking has
been linked to disease states.15 The macromolecular structure of collagen fibers,
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composed of many collagen molecules, is a right-handed coil of interdigitated
microfibers that has been compared to a nanoscale rope.16,17 Due to the tightly bound
superstructure, access to the cleavage site by collagenase is restricted.17 This view of the
collagen superstructure may explain why collagen fiber bundles are less sensitive to
degradation by collagenase than collagen monomers. In summary, collagen is organized
hierarchically on several length scales and can self-assemble into large superstructures
that contribute to the bone matrix.

Figure 1-5 | The collagen triple helix. (a) Repeating tripeptide amino acid motif, where
Xaa and Yaa can be any amino acid, most frequently proline and hydroxyproline,
respectively. (b) Three-dimensional rendering of the collagen triple helix found in the
protein database entry 1cag, described by Bella et al.18 (c) Schematic of gap region
between telopeptide ends of collagen monomers that leads to the characteristic D-banding
pattern shown with electron microscopy below, from Kadler et al.14
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Figure 1-1-6 | Interstrand hydrogen bonds stabilize the triple helix. From Shoulders
et al.12

1.2.3

Non-collagenous proteins

Non-collagenous proteins (NCPs) found in the bone matrix play multiple roles, including
the regulation of collagen fiber mineralization, sequestration and presentation of growth
factors, and matrix organization.6 Many details of NCP function are still being elucidated,
and what we know about NCP function to date is derived from gene deletion or
overexpression studies, in vitro cell and biomineralization assays, and human disease
phenotypes linked to mutations in NCP genes. NCPs can be grouped as follows into four
general classes of molecules (i) Proteogylcans, (ii) Glycoproteins, (iii) Glycoproteins of
the SIBLING family, and (iv) Gla-proteins.

Proteoglycans consist of one or a number of core proteins linked with long
glycosaminoglycan (GAG) chains, with the exception of hyaluronan, which lacks a core
protein. GAG chains are composed of repeating disaccaride units and are very
hydrophilic, enabling the formation of strong hydrogels.19 In the growth plate of the
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developing skeleton, the heparin sulfate proteoglycan perlecan can be found localized in
the extracellular space of chondrocytes.20 Human mutations of the perlecan gene are
associated with major skeletal abnormalities.21 It is thought that perlecan regulates
endochondral ossification through cell-matrix interactions. Other proteoglycans,
classified as small leucine-rich proteoglycans (SLRPs), such as decorin, biglycan, and
fibromodulin, bind to collagen and growth factors, such as TGF-β. In particular, deletion
of biglycan leads to reduced trabecular bone, indicating it is a positive regulator of bone
formation.22 Furthermore, decorin has been shown to be a regulator of collagen
fibrillogenesis. Mutations in the decorin gene lead to mice with fragile skin and abnormal
collagen fibril formation.23

Glycoproteins contain oligosaccharide side chains that can be highly modified following
translation. The enzyme alkaline phosphatase (AP) is a glycoprotein that is frequently
used a histological marker of bone formation, since it is highly expressed during
osteogenesis. AP can be found on the cell membrane and within the bone matrix. Mice
lacking the gene for AP have a poorly mineralized skeleton with fewer trabaculae.24
While the function of AP is still being elucidated, one hypothesis is that it regulates
mineralization by reducing the pool of inorganic pyrophosphate.24 Inorganic
pyrophosphate has an inhibitory effect on bone formation, and a reduction of this
molecule by AP would enable mineralization. Another glycoprotein, Osteonectin, is a so
called “matricellular protein” since it is a primarily nonstructural matrix protein, but
instead performs roles such as binding calcium, collagen, cells, and growth factors.25,26
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Osteonectin has also been implicated in regulation of the cell cycle and cell adhesion.26
Other matricellular proteins found in bone include tenascin, tetranectin, and periostin.6
Glyocosylated proteins known as small integrin-binding ligand, N-glycosylated
(SIBLING) proteins play important roles in cell attachment and growth factor
presentation. These include Osteopontin, Bone Salioprotein, Dentin Matrix Protein, and
fibronectin. All of the SIBLING proteins contain the cell attachment motif RGD27. In
particular, osteopontin and bone salioprotein, which both strongly bind Ca2+, can bind
osteoblasts to the mineral surface.6 Furthermore, fibronectin has been shown to amplify
growth factor signaling due to the close proximity of integrin and growth factor binding
domains within this protein.28 This synergy has been exploited to develop synthetic
matrices containing fibronectin fragments for improved delivery of growth factors.29
Gla (γ-carboxylated) proteins contain glutamate domains that are post-translationally
modified to form γ-carboxyglutamate. This modification bestows a protein with a
formerly weak calcium-binding domain (glutamate), with a new and stronger calcium
affinity (γ-carboxyglutamate).30 The gla-protein Osteocalcin is expressed in osteoblasts
and osteocytes31 and is thought to negatively regulate bone formation32. Mice
homozygous for the deletion of Osteocalcin initially did not have an apparent phenotype,
however older mice (6-month old) had greater cortical bone thickness.32 Another glaprotein found in the bone matrix is matrix gla protein (MGP), which is expressed in
smooth muscle cells and chondrocytes. MGP null mice show mineralization of the
arteries and growth plate cartilage, suggesting MGP is an important inhibitor of matrix
mineralization.33
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Notable NCPs involved in the regulation of bone formation, but not produced
endogenously, are serum proteins Albumin and α2HS-glycoprotein (also known as
Fetuin). Both of these proteins can bind to HA and inhibit crystal growth.6,34 While found
in the bone matrix, the precise role of Fetuin is not clear, however some evidence
suggests that inhibition of crystal growth outside of the collagen fibers can make crystal
growth inside the fibers more favorable.35

In summary, while NCPs are present in relatively smaller amounts than collagen and HA,
they nonetheless play very important and often multiple roles in the regulation of
mineralization and remodeling. Mutations in just a single NCP can lead to dramatic
skeletal abnormalities.

1.1 Bone cell biology
The cell biology of bone involves a diverse set of players with functional implications
both in and outside of bone36. One way of discussing the cells in bone is to divide them
into two lineages, (i) the mesenchymal lineage leading to osteoblasts (bone forming cells)
and the embedded osteocyte, and (ii) the hematopoietic lineage, which among others,
leads to the multinucleated osteoclast (bone removing cell).

1.2.4

The mesenchymal lineage leading to the osteocyte

Mesenchymal stem cells represent roughly 0.001% to 0.01% of cells in the bone marrow
and can differentiate to form osteoblasts, chondrocytes, adipocytes, and myoblasts.37
14

These cells occupy a perivascular niche in the bone marrow,38 and have been shown to
contribute to the patency of new vessels.39 In response to the natural turnover of boneforming osteoblasts, mesencyhmal stem cells can differentiate into osteoprogenitor cells,
followed by osteoblasts, and later osteocytes (Figure 1-7). Defining unique markers for
MSCs has been difficult to do, although a combination of surface markers such as STRO1, CD90, CD71, CD29, and CD44 are often used.37,40 Additionally, Grcevic et al.41 and
Liu et al.42 have generated transgenic mice with fluorescent markers using promoter
regions from the SMAA and TWIST genes, respectively, to define a population of
multipotent progenitors in the bone marrow. Furthermore, marker genes based on
portions of the COL1A1 promoter region have been used identify populations of early
and mature osteoblast cells.43

Several proteins are involved in the regulation of osteoblast differentiation from MSCs,
including PTH, TGF-β, BMPs, WNTs and Hedgehogs, however the transcription factor
Runx2 (also Cbfa1) is thought to be the master regulator of osteoblast differentiation.44
RUNX2 −/− mice show a complete lack of bone formation45 and heterozygous mutations
in RUNX2 share similar phenotypes to the rare human syndrome cleidocranial
dysplasia46. Runx2 can both positively and negatively regulate a number of bone-related
genes such as COL1A1, ALP, ON, OSTERIX and OC.44 A model of the pathways that
interact with Runx2 is pictured below (Figure 1-8).

Following differentiation into osteoblasts, part of this population becomes osteocytes
embedded in cortical bone. Osteocytes form an interconnected network of long, dendritic
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processes inside cavities in the cortical bone known as the lacunocanicular network
(Figure 1-10). Osteocytes have long been thought to regulate bone turnover through
mechanotransduction, yet this process is poorly understood.47 Recent work has
demonstrated that osteocyte projections are particularly sensitive to fluid shear stress,
which in turn activates Ca2+ signaling amongst the osteocyte network.48 Osteocytes have
also been shown to regulate osteoblast and osteoclast activation through secretion of
soluble factors and direct cell-cell contact.2

Figure 1-7 | Differentation of MSCs toward osteoblasts and osteocytes. From de
Gorter and ten Dijke.44
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Figure 1-8 | Pathways converging on Runx2, a master regulator of osteoblast
differentiation. From de Gorter and ten Dijke.44

Figure 1-9 | The lacunocanicular network. Scanning electron micrograph of resinembedded lacunocanicular network following acid etching. Image from Bonewald.49
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1.2.5

The hematopoietic lineage leading to the osteoclast

The bone marrow supports the production of red blood cells (~1 billion RBCs/hour)50,
immune cells, and the bone-remodeling cells known as osteoclasts. Immune cells,
platelets, RBCs, and osteoclasts are all derived from a single progenitor known as a
hematopoietic stem cell (HSC) (Figure 1-10). The lineage progression from HSC to
osteoclast, shown below (Figure 1-11), depends on receptor activator of nuclear factorκB ligand (RANKL) and macrophage colony stimulating factor (M-CSF) to fuse multiple
macrophage cells, which differentiate into a large multinucleated osteoclast.

Bone modeling and remodeling is regulated by interconnected signals from osteoblasts,
osteocytes, osteoclasts, and even organs outside the bone. This balancing act between
bone formation (modeling) and removal (remodeling) is regulated in part through
RANKL signaling (Figure 1-12). In a bone-remodeling scenario, osteoblasts and
osteocytes secrete RANKL and other factors that activate osteoclastogenesis and
osteoclast-mediated bone remodeling. By contrast, considering a modeling scenario,
osteoblasts and osteocytes produce osteoprotegerin (OPG), which binds to RANKL, and
therefore inhibits RANKL mediated osteoclast activation.

Once activated, osteoclasts form a tight seal around the bone surface, mediated by αvβ3
integrins which bind to RGD motifs on proteins within the bone.51 The osteoclast then
creates an acidic microenvironment (pH ~4.5) by secretion of H+ and Cl− ions through the
combination of a proton pump (H+-ATPase) and chloride ion channels.52 The acidic
microenvironment dissolves the hydroxyapatite mineral and exposes scaffolding proteins
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such as type I collagen. Osteoclast secretion of Cathepsin K and matrix
metalloproteinases (MMPs) cleave and digest the underlying collagen.

In summary, MSCs produce the bone forming osteoblast and HSCs produce the bone
remodeling, multinucleated osteoclast. The delicate balance between bone formation and
removal is orchestrated in part through RANKL signaling between osteoblasts,
osteocytes, and osteoclasts.

Figure 1-10 | Hematopoietic lineage tree. LT-HSC Long term reconstituting
hematopoietic stem cell , ST-HSC Short term reconstituting hematopoietic stem cell,
MPP – multipotent progenitors, CMP – common myeloid progenitor, MEP megakaryocyte erythrocyte progenitor, CLP – Common lymphoid progenitor, GMP –
Granulocyte monocyte progenitor. From Wang and Wagers.50
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Figure 1-11 | The formation of osteoclasts starting from hematopoietic stem cells.
From Boyle et al.53

Figure 1-12 | Interaction of osteoclasts, osteoblasts, and osteocytes controlling bone
modeling and remodeling. From Baron and Kneissel.54
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1.3 Bone healing
Bone is one of the few human tissues endowed with the extraordinary ability to heal
completely without the formation of scar tissue. However, roughly 10% of all bone
fractures fail to heal due in part to aging, diabetes, or smoking.55 Bone healing is a tightly
orchestrated cascade that involves the expression of thousands of genes as cells migrate
to a site of injury and differentiate, ultimately forming new tissue through a series of
stages. The overlapping stages of gene expression can be broadly classified, in the order
they occur following injury, as inflammatory, chondrogenic, and osteogenic (Figure 113). In humans, the stages to completion of healing require several months, whereas the
mouse (used as a model herein) will heal significantly faster.

Immediately following bone injury, a hematoma forms (Figure 1-14A) consisting of
platelets and red blood cells entangled in a fibrin matrix, which stems from the precursor
fibrinogen found in the bloodstream. Macrophages and other immune cells from the
bloodstream invade the hematoma and secrete pro-inflammatory cytokines TNF-α, IL-1,
IL-6, IL-11, and IL-18 that recruit MSCs from the surrounding tissue and stimulate
angiogenesis.56 MSCs are found in a number of regions near the site of injury such as the
marrow, periosteum, and adjacent muscle. Some evidence suggests that progenitors
found in the periosteal layer may be the primary contributor to fracture repair.55 Once
activated by inflammatory cytokines, osteoprogenitors rapidly proliferate and migrate
towards the site of injury (Figure 1-15). The periosteal layer thickens as cells proliferate
and a cartilaginous callus is formed in the hypoxic core of the defect (Figure 1-14C
through D). Hypoxia is a well-known inducer of cartilage formation.57 Cartilage also
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forms in areas of mechanical instability, to later undergo endochondral ossification. By
contrast, in well-stabilized fractures, bone formation can occur by intramembranous
ossification, completely forgoing the cartilage intermediate step.58 As blood vessels
invade a cartilaginous callus, bone formation proceeds by the endochondral mechanism
(Figure 1-14E). Mineral formation also occurs on the perimeter of the callus, which
bridges the two ends of the fracture. The oversize mineralized callus, consisting of
loosely organized woven bone, is remodeled by osteoclasts to return to the anatomical
shape and lamellar microstructure of the bone pre-injury (Figure 1-16 and Figure 1-14E).

Figure 1-13 | Expression of selected genes following fracture. (A) Polyacrylimide gel
showing products from a ribonuclease protection assay from fracture samples at different
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times following injury. L32 is a housekeeping gene expected to be contast over the time
period examined. (B) Schematic representation of the three general categories of gene
expression following injury. From Cho et al.59

Figure 1-14 | The progression of fracture repair. (a) Organization of bone prior to
injury. (b) Fracture occurs and hematoma forms at the site of injury. (c) Periosteum
thickens and ossifies at the ends, while cartilage forms in the core of the defect. (d)
Cartilage maturation. (e-f) Blood vessels invade the cartilage and begin endochondral
ossification. (g) Loosely organized woven bone is slowly remodeled into the original
anatomic structure pre-injury. Schematic from Zuscik.55
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Figure 1-15 | Invasion of osteoprogenitors following a bone defect. Shown here is the
temporal progression of osteprogenitors (red) invading a circular defect (border shown by
dotted line) in a mouse calvarium. Once inside the defect, osteoprogenitors differentiate
into osteoblasts (green, double positive appear yellow) and form new bone (blue) in the
defect. Some cells can be seen embedded in the new bone matrix (blue) at Day 21. From
Park et al.60

Figure 1-16 | Remodeling phase of a mouse fracture callus three weeks after injury.
(A) Early and mature osteoblasts are indicated using marker genes Osteocalcin (green)
and Col3.6cyan (blue), respectively. Sites of active mineralization are labeled in red.
Yellow in (B) and (C) indicate TRAP activity from osteoclasts. From Ushiku et al.61
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1.4 Bone Tissue Engineering
1.4.1

The promise of bone regeneration, current approaches, and challenges

Large bone defects arise due to trauma, tumor resection, or congenital disorders. The gold
standard material for bone grafting is autologous bone, which is simply bone from the
patient, and is thus immune-compatible and highly osteogenic. However, in the case of
large defects there is simply not enough bone on the patient. Alternatively, bone
regeneration can be realized with the use of a scaffold material combined with cells,62–65
morphogenetic factors66 or some combination of the two67. At present, a scaffold material
alone has not induced bone formation in vivo, and thus exogenous factors or cells are
required.68

In 1965, Marshall Urist discovered that demineralized bone, when implanted
intramuscularly in rabbits, restarted the developmental process of bone formation.69 This
led him to surmise that demineralized bone contained factors that induced de novo bone
formation, forming the foundation for the later description of the BMP family of growth
factors.70 At present, only three growth factors are FDA-approved for orthopedic
applications. These include recombinant BMP-2 (Infuse, Medtronic), BMP-7 (OP-1,
Stryker) and PDGF-BB (Augment, BioMimetic Therapeutics).71,72 Compared with cells
of possibly unknown differentiation state and osteogenic potential, therapeutic factors can
be better defined. For instance, the number of mesenchymal stem cells in the bone
marrow decreases with age73 and is also affected by disease state such as diabetes74. This
feature makes growth factor approaches easier to regulate and gain approval than their
cell-based counterparts. Furthermore, BMP-7 delivery in a polycaprolactone scaffold
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more consistently healed sheep segmental defects than autologous MSC delivery in the
same scaffold (Figure 1-17).66 However, clinical growth factor doses are far higher than
found physiologically, on the order of mg/mL versus ng/mL concentrations.75 For
instance, recombinant OP-1 packaged for use in 3.5 mg vials corresponds to more than
twice the amount found in two entire human skeletons.76 In the case of BMP-2,
supraphysiologic concentrations are linked to adverse effects in humans, including but
not limited to, ectopic bone formation, osteolysis, and elevated cancer risk.77 One might
ask: why do therapeutic growth factor concentrations need to be so high? One
explanation is that the above-mentioned growth factors are delivered without critical
cofactors often found in the extracellular matrix. Martino et al.29 recently demonstrated
that when a fibronectin fragment was delivered along with PDGF-BB and BMP-2, ng/mL
(instead of mg/mL) concentrations were capable of healing rat calvarial critical-size
defects. While this approach would need to be examined in larger animal models where
higher growth factor concentrations are required, this result shows promise for future
growth factor-based bone regeneration and highlights the role of ECM proteins in
mediating signaling. However, in their present form, supraphysiological doses of growth
factors for bone healing are associated with significant safety concerns.

In stark contrast to the delivery of one or two growth factors, bone healing is a tightly
orchestrated cascade involving thousands of genes, which on the order of hundreds are
secreted factors.59,78,79 Cell-based approaches leverage the intrinsic ability of cells to
sense and react to these many different signals. Cells are able to respond to
microenvironmental cues by releasing factors, migrating, or organizing in well-defined
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patterns within strict temporal and spatial scales.80 This exquisitely controlled behavior
decreases the likelihood of off-target effects. Cells can also be genetically modified to
provide additional control, such as an apoptosis circuit to prevent aberrant proliferation
and tumor formation.

Several cell sources could be implemented in a tissue-engineering strategy, foremost
among them are mesenchymal stem cells (MSCs) found in the bone marrow.81 Some
studies have suggested that MSCs are immunopriveleged due to a lack of specific
histocompatibility antigens.82 If indeed safe and equally effective as autologous cells, this
would broadly expand the pool of MSCs for therapeutic use. Other cells being
investigated for regenerative potential are adipose-derived stem cells, human umbilical
vein cells, and periosteal cells.83 Additionally, satellite cells in the surrounding skeletal
muscle can differentiate into osteoblasts.84 Pluripotent stems cells such as human
embryonic stem cells (hESCs) or induced pluripotent stem cells (IPSCs) can also be used
to derive osteoblasts. IPS-derived osteoblasts could provide a source of patient-specific
cells from a skin biopsy.

Tissue engineering strategies involving a patients own cells have shown promising results
in the clinic.62,85–87 In the only published study of bone tissue engineering in humans, four
patients with large diaphyseal defects were treated with porous hydroxyapatite scaffolds
and autologous culture-expanded bone marrow cells.62 All patients recovered limb
function, and in 3 of the 4 patients re-examined 6 years following the procedure, the
implant was completely fused to the host bone, providing evidence for the long-term
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efficacy of a cell-based approach (Figure 1-18). This group proposes “the use of cultureexpanded osteoprogenitor cells in conjunction with porous bioceramics as a real and
significant improvement in the repair of critical-sized long bone defects.” This group
notes that controlled clinical trials will ultimately have to be undertaken in order to
definitively evaluate the effectiveness of a tissue engineering strategy versus other
approaches. Additionally this study found that the ceramic scaffold was still mostly
present at 6-7 years post-implantation (Figure 1-18). Cracks in the ceramic scaffold were
reported, which could comprise the mechanical integrity of the overlying bone. Therefore
it would be advantageous to the patient to use a scaffold with a degradation rate that
matches the rate of new bone formation. Furthermore, bone formation was localized to
the external surfaces of the ceramic scaffold. This was thought to be due to
heterogeneous cell loading or better cell survival at the external surfaces. Thus cell
seeding and survival following implantation should be examined and may require
improvement.

Due to the difficulty of the defects found in the patients, a control group involving a
scaffold without cells was not used. Therefore, this work did not provide evidence of the
therapeutic value of the implanted MSCs. By contrast, the contribution of MSCs to bone
repair has been demonstrated in numerous animal models (Figure 1-19),64,65,88,89 however
the success rate of this method has been less than 50% in some large animal studies65,66.

Bone tissue engineering with marrow stromal cells has shown limited clinical success and
lagged behind growth factor-based approaches, in part due to technical hurdles such as:
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(i) an incomplete understanding of how transplanted cells mediate bone repair in vivo, (ii)
a poor understanding of cell manipulation prior to implantation and optimal methods
thereof, and (iii) current scaffolds are still largely nonphysiological and thus rely on
comparatively less potent signaling mechanisms than the in vivo milieu. The specific
aims presented in Chapter 2 were formulated to directly address these limitations.

Figure 1-17 | Comparison of cell-based versus growth factor-based bone tissue
engineering in sheep segmental defects. Radiographs of defects following 3 months of
implantation with either (B) autologous bone, (C) a PCL scaffold, (D) a PCL scaffold +
BMP-7, (E) a PCL scaffold + autologous MSCs or (A) an empty defect used as a
negative control. From Reichert et al.66
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Figure 1-18 | Bone tissue engineering using culture-expanded MSCs in humans. Xray (gray) and CT scan (blue) of bone defect filled with culture-expanded hMSCs before
and after surgery. The defect was the result of an unsuccessful bone-lengthening attempt.
From Quarto et al.62

30

Figure 1-19 | Healing large defects using culture-expanded MSCs in sheep. Histology
(top row) and radiographs of defect sections (bottom row) 16 weeks after implantation.
(A-B) Control-no cells or scaffold. (C-D) Coral scaffold alone. (E-F) Coral scaffold plus
fresh bone marrow. (G-H) Coral scaffold plus culture expanded bone marrow MSCs.
From Petite et al.65

1.4.2

Scaffolds for Bone Tissue Engineering

Scaffolds for bone repair include synthetic polymers (poly-L-lactide, polycaprolactone,
poly-lactic-co-glycolic acid), proteins (collagen, fibrin, hyalulronic acid), calcium
phosphates (β-tricalcium phosphate, hydroxyapatite, substituted hydroxyapatites, natural-
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occurring corals) or some combination of these materials.90 Several graft materials, which
designed for use with bone marrow aspirate, are currently available or approaching the
market. These are included in the table below.

Product
Collagraft

Manufacturer
Zimmer

Actifuse

Baxter

Healos

Depuy

Ossimend
Mozaik
InQu
Augment

Collagen Matrix
Integra LifeSciences
ISTO Technologies
BioMimetic
Therapeutics

Materials
Bovine type I collagenhydroxyapatite/tricalcium phosphate granules
Silicon substituted hydroxyapatite – resorbable
polymer
Bovine type I collagen-coated with
hydroxyapatite
Type I collagen – bone mineral
Collagen- tricalcium phosphate granules
PLGA-hyalulronic acid
Bovine type I collagen-carbonated apatite
granules

FDA status
Approved
(PMA)
Approved (510k)
Approved (510k)
Approved (510k)
Approved (510k)
Approved (510k)
PMA in process

Table 1 | Scaffolds indicated for use with bone marrow aspirate that are on or
approaching clinical use.

Previously, our lab has developed a scaffold composed of type I collagen and
hydroxyapatite (Figure 1-20).89,91,92 This material combination is based on mimicking the
collagen and apatite content found in native bone. The collagenous phase is easily
mineralized13 or degraded by MMPs during healing,93 allowing for fast remodeling. The
calcium phosphate phase provides ions94,95 and a osteoconductive substrate for mineral
apposition. Furthermore, the fabrication process is gentle enough to accommodate the
addition of protein therapeutics. However, this and other scaffolds that define the state of
the art are still largely nonphysiological when compared to the extracellular matrix of the
wound microenvironment.

Following injury, fibrinogen combines with thrombin and other clotting factors to form a
clot consisting of platelets, fibrin, and other small molecules.56 Studies in a limb-
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regenerating newt model have found that following the initial clot, a transitional matrix is
formed consisting of tenascin, fibronectin, and vitronectin.96 A cartilaginous soft callus is
then formed that stabilizes a fracture, which is then ossified before being gradually
remodeled back to the original form (endochondral ossification). Alternatively, bone
healing may skip the intermediate cartilage deposition step and bone is produced more
directly (intramembranous ossification), as is the case in many craniofacial bones.56 More
recently, Zeitouni et al. found that the co-delivery of human mesenchymal stem cells
along with their cell-specific extracellular matrix (ECM) enhances bone formation in a rat
calvarial defect model.88 Human MSCs seeded in their in vitro secreted matrix and
implanted into a critical size defect produced significantly more bone than either cells or
matrix alone after 3 weeks of implantation. To increase matrix production in vitro, cells
were treated with a molecule (GW9662) to promote osteoblastic differentiation. Due to
the insolubility of the cell-secreted material, it was difficult to perform a traditional
proteomic analysis that would describe the precise composition of the cell-secreted
matrix. Instead this group examined the gene expression of cells with GW9962, which
produced more matrix than untreated cells, and found that type I, III, V, VI, XI, XII, XIV,
XV, and XXI collagen genes were up-regulated. Nonfibrillar collagens (such as type V,
VI, XI, XII, XIV and XV) play a role during skeletal development, and were suggested to
be responsible for the enhancement in osteogenesis. Additionally, this group suggested
that bioconditioning of orthopaedic biomaterials may confer a similar advantage. Since a
control scaffold was not included, it is not clear from this study that a cell-secreted matrix
confers an additional advantage beyond acting as a scaffolding material.
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Lin et al. reported that MSC-derived matrices significantly increased proliferation,
attachment, migration, and differentiation compared to type I collagen.97 This result
suggests an improvement over type I collagen sponges for bone repair. In contrast to
Zeitouni et al., Lin et al. attribute the observed enhancement to non-collagenous proteins.
Further work is needed to elucidate the role of ECM proteins in bone repair, however the
ability to leverage the signals provided by the ECM to promote regeneration could
improve the efficacy of cell-based bone repair strategies.

Figure 1-20 | Collagen-HA scaffold fabrication. A collagen-HA composite is made by
collagen fiber self assembly in the presence of HA nanocrystal precipitation from a
physiological salt solution. Then a mixture of water and the collagen-HA composite is
frozen in one of three systems: (1) culture dish, (2) single sided mold and (3) double
sided mold. The single sided mold cools in the upward direction via a copper plate at the
base that is exposed to the cooling shelf of a freeze dryer. The double sided system has
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integrated temperature control of the top and bottom copper surfaces, allowing tuning of
the freezing rate.98,99

1.5 2-Photon Microscopy
The unique value that 2-photon microscopy provides is the ability to generate a threedimensional view of cells in their microenvironment that can be followed through time,
even in living tissue. This method has found application in many fields such as
neuroscience,100,101 immunology,102–105 and skeletal biology60,106, among others.
Compared with other imaging tools such as X-ray tomography or magnetic resonance
imaging, 2-photon microscopy is the only method capable of imaging living biological
tissue at cellular resolution (Figure 1-21). Furthermore 2-photon microscopy is a version
of fluorescence microscopy, which enables the tracking of any cell or molecule of interest
using fluorescent proteins. As new fluorescent markers are developed, further expanding
the already vast library of fluorescent probes, this technique will become even more
useful to the researcher.

The theory of 2-photon fluorescence was described by Maria Goeppert-Mayer in 1931 in
her doctoral dissertation entitled “Über Elementarakte mit zwei Quantensprüngen” which
translates from German to English as: “Elementary Acts With Two Quantum
Jumps”.107,108 Goeppert-Mayer would later win the Nobel Prize in Physics in 1963 for her
theory of the nuclear shell model of the atomic nucleus. She became the second woman
to win a Noble Prize in Physics, following Marie Curie in 1903. It wasn’t until almost 60
year later that this technique was experimentally proven by Winfried Denk and Watt
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Webb at Cornell University.109 Since then, the popularity of this technique has risen
exponentially.110

1.5.1

Multiphoton fluorescence

Fluorescence can be defined as the cyclical process by which a fluorophore is brought to
an excited state, releases energy (through heat and light emission), and returns to a
ground state. This is depicted in Figure 1-22 (top row). First a fluorophore is excited by
an incoming photon of light at a given wavelength. Some energy is lost due to heat in the
form of molecular vibration. The fluorophore then returns to its ground state through the
emission of a wavelength of light that is longer then the excitation wavelength. Noting
light energy is inversely proportional to wavelength (E ~1/ λ; i.e. longer wavelength
corresponds to lower energy), the emission wavelength must be longer than the excitation
wavelength since energy is lost to heat following excitation. The difference between the
excitation and emission wavelength is known as the Stokes shift. For 2-photon excitation,
the same basic process is at play, with the crucial difference being that two photons
provide the excitation energy, each with half the energy required by single photon
excitation (Figure 1-22, bottom row). Furthermore, light scattering (the dominant effect
limiting imaging deep in tissue) scales with 1/ λ4, therefore longer wavelength light
scatters less, allowing deeper penetration with 2-photon sources.

It is important to note that the likelihood of two photons impinging on a fluorophore at
the same exact moment is extraordinarily rare under normal conditions. Denk and
Svoboda illustrate this point through the following example111: Considering if sunlight
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was used as the source, it would take over 10 million years for a 2-photon event to excite
even the most efficient of absorbers. By contrast, single photon events would occur once
every second. Waiting for a 3-photon event would exceed the age of the universe!

Multiphoton excitation requires extremely short-pulse lasers to provide a very high
number of photons to the sample, dramatically increasing the probability of this event
occurring within a suitable timeframe for imaging. This fact is largely why it took almost
60 years after the theoretical groundwork was laid for multiphoton excitation to be
experimentally proven, in particular the development of mode-locked sub-picosecond
pulsed lasers that could provide the required high photon density. An added benefit of
excitation occurring only in regions of high photon density is that the excitation region is
limited to a point for 2-photon microscopy versus an hourglass-like volume for a
confocal microscopy, which is a single-photon technique (Figure 1-23). This translates to
benefits to the user such as reduced photobleaching, less scattering due to out-of-plane
excitation, and no requirement of pinholes (applied in confocal microscopy) used to
block out-of-focus light.
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Figure 1-21 | Imaging modality comparison across temporal and spatial scales. Note
the high temporal and spatial resolution of multiphoton microscopy. From Schroeder.112

Figure 1-22 | Single photon versus 2-photon fluorescence. (Top row) A fluorophore
starting in a ground state is brought to an excited state by an incoming photon of light.
Energy is lost through vibrations and the fluorophore is reduced to a lower, yet still
excited, state. A longer wavelength of light is emitted from the fluorophore, returning it
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to a ground energy state. (Bottom row) 2-photon fluorescence proceeds in the same
manner as single photon fluorescence (top row) except two photons excite the
fluorophore, each with half the energy of the single photon excitation. Fluorophore
pictured is fluorescein isothiocyanate.

Figure 1-23 | Comparison of the excitation volumes of single and 2-photon
fluorescence. Each cuvette holds a fluorescent dye, on the left excited via single-photon
fluorescence and on the right via 2-photon fluorescence. At left, the exciation volume is
large, extending well beyond the focal plane. At right, the 2-photon excitation is a single
point, greatly restricted to the focal plane. Image from Zipfel.110

1.5.2

Second harmonic generation

Another extremely useful aspect of 2-photon microscopy in living systems is the
visualization of some biological molecules with no fluorescent labeling at all. Molecules
such as type I collagen produce a so-called second harmonic signal, which is a frequency
doubling of incoming light through the interaction with the noncentrosymmetric structure
of the collagen triple helix.113–117 For example, if a collagen-containing sample is excited
at 900 nm, a second harmonic signal will emerge at 450 nm. The generation of second
harmonics was first proven in 1961 using quartz and newly developed lasers.118 Ten years
later, second harmonic generation in biological tissues was demonstrated.119 A second
harmonic can be found in any tissue containing sufficient concentrations of type I
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collagen. Since roughly 90% of the inorganic fraction of bone is type I collagen, bone
generates a strong second harmonic signal (Figure 1-25), and the different patterns of
collagen orientation in mineralized and unmineralized tissue can be visualized. Of
particular importance to bone formation, differences between woven and lamellar bone
can be appreciated with this approach. Finally, since the second harmonic signal relies on
the triple helical unit of type I collagen, this method has also been used to differentiate
between triple helical and non-triple helical collagen (gelatin),120 which has important
implications for the how cells interact with this protein.121
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2 Specific Aims
The overall goal of this project was to better our understanding of cell-based bone tissue
engineering and improve in vivo bone defect repair using mesencyhmal stem cells and a
collagen-hydroxyapatite scaffold.

AIM 1 | Establish a 2-photon platform for imaging bone tissue engineering in vivo.
The interactions between cells and biomaterials that lead to osteogenesis are not yet well
understood and are difficult to observe. By providing a description of a tissue
microenvironment across multiple time points in the same animal, 2-photon microscopy
could provide a more continuous perspective than has previously been shown.

AIM 2 | Improve the repeatability of in vivo bone formation with an in-house made
collagen-HA scaffold. A well-defined, open platform is important to the development of
scaffold technology. Thus we must be able to produce scaffolds capable of repeatedly
forming bone.
AIM 2a | Fabricate a sterile collagen-hydroxyapatite scaffold system without
compromising material performance.
AIM 2b | Determine viability, progenitor distribution, and optimal seeding conditions for
murine BMSCs in a collagen-HA scaffold.

AIM 3 | Evaluate the effect of cell-derived ECM in a collagen-HA scaffold to
enhance in vivo bone formation. Current scaffolds are still largely nonphysiological and
thus rely on comparatively less potent signaling mechanisms than the in vivo milieu. The
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application of ECM combined with collagen-HA scaffolds could improve cell-based bone
formation.
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3 Visualizing Osteogenesis In Vivo Within a Cell–
Scaffold Construct for Bone Tissue Engineering Using
Two-Photon Microscopy

3.1 Introduction
Regeneration strategies employing a scaffold material combined with cells have shown
early success in the clinic,,85 with others rapidly approaching this stage.122,123,124 However,
the cellular mechanisms underlying regeneration are not yet well understood.125,126
Describing the progression of host-donor-biomaterial interactions behind a successful or
unsuccessful therapy is still a difficult process, yet is central to the safe transfer of basic
research to a clinical setting. For example, what is the fate of seeded cells? How do these
cells induce or conduct repair? What are the cell and scaffold interactions governing a
successful or unsuccessful therapy? In order to understand the impact of a given
regenerative strategy on the resultant cellular interactions, it is first necessary to observe
them.

In vivo microscopy has dramatically contributed to our understanding of development,127
neuroscience,100,128–130 immunology102,104,105,131–133 and stem cell dynamics60,106,134. Much
of this work relies on 2-photon microscopy, the theoretical foundation of which was
conceived in 1931107 and put into practice in 1990.109 Due to a longer excitation
wavelength than conventional fluorescence microscopy, 2-photon microscopy provides
deeper tissue penetration, allowing observation of cellular dynamics in situ and in vivo.103
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Additionally, a longer excitation wavelength enables collagen to be visualized in vivo
without the use of an additional stain due to its generation of a second harmonic
signal.114,117,135,136 More recently, in vivo fluorescence imaging and 2-photon microscopy
have been applied to tissue engineering applications.39,137 Concurrently, X-ray
tomography64,138 and whole body fluorescence measurements139 have also provided
insights into the cellular interactions governing regeneration in live animals. However, at
present, whole body fluorescence imaging does not facilitate single cell resolution and Xray tomography does not allow integration with fluorescent reporter genes.112 Fluorescent
reporter genes have allowed tracking of lineage specific cell populations in vitro or in
vivo without additional stains. Histology can provide a large field of view of reporter
gene activity within a tissue of interest, however, the process compromises the viability
of the tissue and the microenvironment can be physically disturbed due to sectioning.
Therefore, 2-photon microscopy has the distinct advantage of visualizing tissue at singlecell resolution in vivo and in situ in three dimensions.60 By providing a description of a
tissue microenvironment across multiple time points in the same animal, 2-photon
microscopy provides a more continuous perspective than has previously been shown
using different animals at each time point.

This paper describes the establishment of a 2-photon microscopy platform to examine
cell-scaffold based therapies for bone regeneration in vivo. To establish a live animal
imaging platform, experiments were conducted in two steps: (i) to describe the initial
calvarial microenvironment prior to injury repair, and (ii) to observe the interaction of
cells, scaffold, and new bone during tissue-engineered regeneration in a calvarial defect
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model. In order to provide an unambiguous description of the spatial context in which the
three dimensional 2-photon data reside, the microenvironment of calvarial bone is
described starting with two-dimensional techniques of histology and stereomicroscopy,
and then with three-dimensional 2-photon live animal microscopy. Each imaging
technique provides a different perspective; stereomicroscopy provides a global view,
histology a cross-section, and 2-photon a three dimensional volume.

We have previously employed a calvarial defect model of bone repair in combination
with transgenic mice carrying reporters for cells in the skeletal lineage.89,92,140 In order to
assess the cellular interactions within our cell-scaffold system, a murine critical size
calvarial defect model was used because the calvarium is thin and reasonably accessible
to a microscope objective. Tissue engineered bone formation was observed in animals at
four and six weeks after implantation of a scaffold and donor bone marrow stromal cells
(BMSCs). 2-photon microscopy during tissue engineered bone formation enabled
visualization of host cells, donor cells, scaffold and type I collagen at two time points, in
vivo and in situ.

3.2 Materials & Methods
3.2.1

Live animal imaging

A bone mineralization label (alizarin complexone) was injected into the tail vein of the
mouse to be examined one day prior to an imaging session. On the day of imaging, the
mouse was anesthetized with a ketamine (135 mg/kg) – xylazine (15 mg/kg) blend. If the
vasculature was to be visualized, 100 µL of rhodamine-labeled dextrans (50 µg/µL) were
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injected into the tail vein. The skin above the calvarium was shaved and a u-shaped
incision was made (Fig. 3-1a). The skin flap was sutured to an area above the nose and
the animal was placed in a stereotaxic frame (Mouse and Neonatal Rat Adaptor #51625,
Stoelting). The head was stabilized at three points by two blunt ear bars and a bite bar
(Fig. 3-1a). The animal was then placed beneath a 2-photon microscope (Ultima IV,
Prairie Technologies, Fig 3-2). Adjusting the height of the ear bars leveled the exposed
calvarium. The calvarium was imaged with a water immersion objective (XLUMPlanFL
20x/0.95W, Olympus) in sterile PBS. To acquire a stack of images through the depth of
the calvarium, a 459 by 459 µm area was scanned in the x-y plane while the z depth was
increased by 1 µm increments, controlled by the acquisition software (Prairie Viewer,
Prairie Technologies). All fluorophores were excited at 900 nm and data were collected
in four channels with the following filter limits: channel 4, 435-485 nm; channel 3, 500550 nm; channel 2, 570-620 nm; and channel 1, 640-680 nm. When exited at 900 nm,
type I collagen emits a 450 nm second harmonic; this signal was detected in channel 4.
Cyan fluorescent protein-expressing osteoblasts (Col3.6cyan) were detected in channels 3
and 4. Yellow fluorescent protein-expressing osteoblasts (Col3.6topaz) were detected in
channels 2 and 3. Emerald green fluorescent protein-expressing osteoprogenitors,
osteoblasts, and osteocytes (SMAAemd, Col2.3emd) were detected in channel 3. The
scaffold (Healos®, DePuy) was autofluorescent in all channels. Rhodamine-labeled
vasculature and alizarin complexone mineral label were detected in channel 1, but used
separately in the current study. After the completion of an experiment, z-stacks were
reconstructed in three dimensions using the 3D viewer plugin141 for FIJI.142 This study
used 3-month-old B6 (SMAAemd) and CD1 (Col3.6topaz, Col3.6cyan, Col2.3emd) mice
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(Fig. 3-1a). All procedures in this study were approved by the UConn Health Center
Institutional Animal Care and Use Committee (IACUC).

Figure 3-1| Examination of skeletal cells in native and tissue engineered bone with
live animal microscopy. (a) Reporters of the skeletal lineage used in this study, surgical
procedure and animal stabilization on the microscope. Left, skeletal lineage reporters
used in this study. Middle, the calvarium was exposed by incision and the skin flap was
sutured down. The stereotaxic frame stabilizes the head by three-point fixation at the ear
canals and front teeth. Right, animal positioned under the objective lens of the 2-photon
microscope. (b) Observing tissue engineered bone regeneration. Col3.6topaz BMSCs
were seeded onto a collagen-HA scaffold and implanted into a Col3.6cyan host. Host
animals were irradiated and given a bone marrow transplant to prevent immunorejection
of donor cells. At both 4 and 6 weeks later, animals in the imaging group were examined
by 2-photon microscopy. For comparison, the control group did not undergo imaging
surgery. To visualize the mineral surface, alizarin complexone was injected into both
groups one day prior to sacrifice.
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Figure 3-2 | 2-photon microscope at the University of Connecticut Health Center. At
left, the microscope eyepiece, brass objective lens and stage are shown. At right, the
vibration isolation table with microscope, two femtosecond Ti:Sapphire lasers on the left
and right of the microscopy shroud are pictured. The computer workstation with x, y and
z stage control is also visible.

3.2.2

Calvarial defect model of tissue engineered bone

Bone marrow stromal cells were isolated from the femur and tibia of CD1 wild type and
Col3.6topaz animals for bone marrow rescue following irradiation and scaffold seeding,
respectively. Cells were plated in α-MEM (Gibco) containing 10% FBS and 1%
penicillin-streptomycin. Following isolation, cells were allowed to attach in an incubator
at 5% CO2, ambient O2 and 37 ˚C. After 7 days of culture, Col3.6topaz cells were
trypsinized and seeded onto a collagen-hydroxyapatite scaffold (Healos®, DePuy Spine)
at a density of 1.0×106 cells/scaffold at the time of implantation. To prevent
immunorejection of the cell-scaffold implant, Col3.6cyan host animals underwent 900
rads of irradiation to ablate the bone marrow 1 day prior to implantation. Host animals
subsequently received a bone marrow transplant of 1.5×106 cells from wild type CD1
animals via retro-orbital sinus injection. Animals were anesthetized with a ketamine (135
mg/kg) – xylazine (15 mg/kg) blend and a 3.5 mm diameter defect was introduced in the
right parietal lobe using a Dremel® MultiPro drill with a trephine bit. Extreme care was

49

taken to prevent damage to the dura mater beneath the calvarium. After the scaffold-cell
construct was placed in the defect, the incision was closed with resorbable sutures and the
animals were given analgesic (bupronephrine, 0.08 mg/kg). To enable imaging at four
and six weeks, animals were anesthetized, and an incision was made above the defect
area. To assess the effect of imaging surgery on bone formation, two groups of animals
were used (Fig 3-1b). One group (n=4) underwent surgery to expose the calvarium and
was subsequently imaged with in vivo 2-photon microscopy at four and six weeks postimplantation. The other group (n=4), acting as a control, did not undergo surgery or
imaging. Both groups were sacrificed at six weeks post-implantation and examined with
histology and X-ray imaging.

3.2.3

Histology, stereomicroscopy and X-ray imaging

Concluding a 2-photon experiment, animals were sacrificed by CO2 asphyxiation. The
calvaria were dissected, placed in 10% formalin at 4 °C for 1 day and then in 30%
sucrose solution overnight. Photographs and X-ray images (LX60, Faxitron) were taken.
The calvaria were placed then in sucrose solution in a culture dish beneath the
stereomicroscope objective (Lumar V12, Zeiss). Images were acquired on the
stereomicroscope using a digital camera (Axiocam, Zeiss) and filter set (49002, 31002 &
31043, Chroma). Images were acquired at different locations using stage automation;
these resultant images were stitched together with acquisition software (AxioVision,
Zeiss) in order to capture a large field of view. Following stereomicrosopy, each
calvarium was covered with embedding medium (Cryomatrix, Termo Shandon) and
affixed to an aluminum stage for cryosectioning. Thin sections (7 µm) of tissue were
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transferred via tape (Cryofilm, Section-Lab) to a plastic slide. Sections were then rinsed
three times in PBS, followed by distilled water, and placed on a glass slide. A 50%
glycerol solution was applied to the section and a glass coverslip was placed on top.
Images of finished slides were acquired with a fluorescent microscope (ImagerZ1, Zeiss)
equipped with a digital camera (Axiocam, Zeiss) and filter set (49002 & 31002, Chroma).

3.2.4

Image analysis

To quantify integration of host bone with the edge of the scaffold, a Euclidean distance
analysis106 was performed on X-ray images of calvaria in dorsal view from both groups
using FIJI142. First, the inside edge of the host bone was selected manually with an
elliptical region of interest (ROI) and saved for the following step. The entire image was
then cleared to white (8-bit grayscale value of 255) and the outline of the saved ROI was
drawn in black (8-bit grayscale value of 0) on the white image. A Euclidean distance map
(EDM) was produced from this image, coding each white pixel a grayscale value
corresponding to its distance in pixels from the black ROI representing the edge of the
defect. A duplicate of the original X-ray image was then converted to a binary image (0
or 255 only) by setting pixels above a threshold value to 0 and below to 255, for bone and
non-bone pixels respectively. In order to combine the distance information from the
EDM with the location of bone pixels from the binary image, the pixel values between
the two images were compared, and the maximum value was chosen to form a composite
image. Calculating a histogram of the composite image yielded the number of bone pixels
as a function of pixel distance from the edge of the host bone. White background pixels
(255) in the histogram were excluded from the analysis. The same procedure was
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repeated with the entire defect area set to 0, representing the defect as theoretically filled
with bone, i.e., perfect host-implant integration. To normalize these data, the histogram
derived from the X-ray composite was then divided by the histogram representing perfect
host-implant integration. For each group, the mean value of bone pixels was plotted as a
function of distance from the edge of the defect. Pixel distance was converted to microns
using the spatial calibration for the magnification used.

The area fraction of bone in the defect area was measured from histological sections
using the following method. The defect was cropped with a rectangular ROI and pixels
were classified as either bone or not bone using the WEKA trainable segmentation
plugin143 for FIJI. The user first identified a selection of pixels belonging to each class
(bone, non-bone) and the computer classified the entire image. The misclassification
error was less than 0.2% for images examined by this method. The classified image was
then output as a binary image. An ROI that had been manually drawn around the defect
area was applied to the classified image. A histogram was calculated, resulting in the
number of bone pixels and total pixels in the ROI. Dividing the number of bone pixels by
the total pixels in the ROI gave the bone area fraction in the defect.

To determine the thickness of new mineral on the host bone, an ROI was manually
defined around a second harmonic signal indicative of collagen within mineralized tissue
(Fig. 3-3). Our rationale for classifying a second harmonic signal as collagen within
mineralized tissue is based on observing the morphology of the second harmonic signal
in native bone. We also observed this morphology in areas that appeared to be new bone
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formation in the defect model. When mineral label (alizarin complexone) was
administered, the label localized to the surfaces of this second harmonic signal, indicating
such a morphology was due to collagen within mineralized tissue. After region selection,
the contents of the ROI were set to 255 and processed with the local thickness plugin144
implemented in FIJI. This plugin calculates the thickness of a 2D region using a circle
filling algorithm, coding each pixel a value corresponding to the diameter of the circle it
is contained by. A histogram of the image provided the mean pixel value corresponding
to the mean thickness of new mineral on the host bone. New mineral on the scaffold
surface was determined using the WEKA trainable segmentation plugin to classify pixels
as either scaffold or new mineral. The resultant image was used to calculate the mean
thickness using the local thickness plugin. The mineral apposition rate (MAR) was
calculated by dividing the mean thickness of mineral on either the scaffold or host bone
by the time since implantation.
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Figure 3-3 | Cyan host osteoblasts overlying a second harmonic signal indicative of
collagen within mineralized tissue at the defect margin.

3.3 Results
3.3.1

Surveying the calvarial microenvironment in two and three-dimensions

In order to orient three-dimensional 2-photon data within the context of the surrounding
tissue and aid interpretation of 2-photon data when viewed alone, a Col2.3emd31
transgenic animal was examined with 2-photon microscopy, stereomicroscopy and
histological sectioning in this order. Here we will describe the 2D data obtained by
stereomicroscopy and histology first, followed by the 3D 2-photon data. The Col2.3emd
reporter shows osteocytes and osteoblasts via the emerald green fluorescent protein and
the mineral surface was labeled with alizarin complexone (red). Starting with
stereomicroscopy, a bird’s eye view of the calvarium contained osteoblasts distributed
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throughout marrow spaces in the parietal bone and suture lines (Fig. 3-4a). Osteoblasts
colocalized with the mineralization label covering the endosteal surface (Fig. 3-4b).
Osteocytes could be seen embedded in the cortical bone (Fig. 3-4b, black arrow). Blood
vessels reside within the marrow spaces of the parietal bone (Figs. 3-4b & 3-4c, white
arrows are placed at identical locations). Taken together, this data represents the
repeating motif of parietal bone in the calvarium.

Figure 3-4 | Osteoblasts, osteocytes and mineralization in the calvarium. (a) View of
the left parietal lobe of a Col2.3emd mouse showing osteoblasts (green) and mineral
surface labeled with alizarin complexone (red). The green, red and brightfield channels
are overlaid to show the colocalization of the osteoblasts and new bone label. The sagittal
and coronal suture lines also contain osteoblasts, indicated by the black stars (*). The
horizontal line indicates the approximate location of the cross sectional view shown in (d)
The anatomical locations lambda and bregma are labeled λ and br., respectively. (b) Inset
from (a) shows a magnified view of the marrow spaces located in the parietal bone.
Blood vessels (white arrows in b and c) are seen within the marrow spaces. (c)
Brightfield channel showing the organization of vasculature (white arrow). (d)
Histological section of (a) showing Col2.3emd osteoblasts and osteocytes (white arrow)
in the marrow spaces and cortical bone, respectively. Mineralization label (red) is located
on the surface of marrow spaces. The white line indicates the 139 µm total depth of the 2photon z scan shown in Fig. 3-5a.
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Histology of the 200 µm thick calvarium was used to examine the same tissue in crosssection (Fig. 3-4d). From this perspective, osteoblasts overlie new mineral on the
endosteal surface (Fig. 3-4d). Osteocytes are also visible in the histological view,
occupying sites within the cortical bone (Fig. 3-4d, white arrow). The histological
description taken together with the dorsal view obtained by stereomicroscopy more
rigorously defines the three-dimensional microanatomy. The section pictured in Figure 34d shows marrow spaces approximately 100 µm from the periosteal surface of the bone
to their center. Due to light scattering, the 2-photon microscope cannot image completely
through the calvarial bone, however, marrow spaces are routinely reached. The white bar
in Fig. 3-4d indicates the maximum depth (139 µm in this case) of the 2-photon stack
shown in Fig. 3-5a.

Lastly, the 2-photon z-stack previously taken of the parietal bone from the same animal
shows a woven pattern of collagen fibers at the surface of the calvarium, visible by its
second harmonic signal114,117,135,136 (Fig. 3-5a, 10 µm). As the scan moves into the
calvarium, many dendritic osteocytes were visible occupying lacunae in the cortical bone
(Fig. 3-5a, 34 µm). Moving into the marrow space (Fig. 3-5a, 64 and 93 µm), Col2.3emd
osteoblasts are seen at high density lining the endosteal surface labeled in red. At 120 µm,
the sharpness of the image begins to degrade due to scattering in the tissue (Fig. 3-5a, 120
µm). The description of the calvarial microanatomy with stereomicroscopy, histology,
and 2-photon microscopy provides a robust framework for the interpretation of 2-photon
data when viewed alone.
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Figure 3-5 | 2-photon live animal imaging of skeletal reporters in pristine bone. (a)
2-photon z-stack through mouse calvarial bone carrying a Col2.3emd reporter (green) and
alizarin mineral label (red). Red square on leftmost diagram indicates the x-y imaging
location. 10 µm slice shows collagen fibers, white arrow. 34 µm slice contains osteocytes,
red arrow. (b) Parietal bone carrying a Col3.6topaz reporter (green) and rhodamine
labeled dextran in the vasculature (red). Osteoblasts localize in the area between the
vasculature and the endosteal surface of bone. (c) Stereomicroscopy (leftmost panel) and
2-photon z-stack of suture line containing SMAAemd osteoprogenitors (green) and
rhodamine labeled blood vessels (red). (d) Z-stack of SMAAemd osteoprogenitors shown
in inset of (c). (e) Stereomicroscopy (leftmost panel) and 2-photon z-stack of large blood
vessels in the parietal bone labeled with SMAAemd. (f) Smooth muscle cells labeled with
SMAAemd wrap around rhodamine labeled blood vessels.

3.3.2

2-Photon imaging of skeletal lineage reporters

We used the reporters SMAA145 (osteoprogenitors), Col3.643 (early osteoblasts)
Col2.331,43 (mature osteoblasts and osteocytes), (Fig. 3-1a) in order to describe their
baseline expression in the cellular microenvironment prior to use in later experiments.
The starting tissue is rarely characterized prior to a regeneration study, yet this is an
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important step in understanding where responsible cells may originate. Col3.6 osteoblasts
are present in the marrow spaces of the parietal bone and inside the suture lines. Blood
vessels residing in the marrow space were visualized with a rhodamine injection (Fig. 35b). The SMAA transgene marks vascular lining cells, myofibroblasts, and a population
of osteoprogenitor cells.145 We observed SMAAemd cells in the suture lines (Figs. 3-5c
& 3-5d) and in the smooth muscle lining of blood vessels (Figs. 3-5e & 3-5f). This result
implies that in a repair scenario involving resident SMAA osteoprogenitors, these cells
would have to migrate from the suture lines to the site of injury. Taken together, these
data form a part of the host’s cellular initial conditions preceding a bone defect in the
calvarium.

Collagen content and organization contribute to the mechanical properties, mass transport,
and cell motility of living tissue.146 Collagen is readily observed in the calvarium by its
generation of a second harmonic.114,117,135,136 We observed distinct features of collagen
organization in the calvarial suture microenvironment. On the upper surface of the
calvarium, the periosteal membrane contained highly organized collagen fibers in a
woven pattern (Fig. 3-6, red star, 19 µm). Deeper down, inside the cortical bone (Fig. 3-6,
63-109 µm), collagen within mineralized tissue produces a more uniform second
harmonic signal than nonmineralized membranous collagen. Within the suture space
there are many strands of wavy collagen fibers. These strands, collectively known as
Sharpey’s fibers,147 terminate in bundles along the wall of the marrow space at a regular
interval , 109 µm). Second harmonic imaging also allowed stain-free visualization of
collagen-based scaffolds (Fig. 3-7).135 These results provide the template of collagen in
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the periosteal membrane, suture space, and cortical bone in the host calvarial
microenvironment preceding injury.

Figure 3-6 | Collagen organization in the calvarial suture microenvironment. Second
harmonic signal shows the organization of collagen fibers in the suture space. 19 µm: The
top layer of the calvarium shows loosely organized fibers (red arrow) followed by more
densely packed woven fibers (red star). 29 µm: Woven collagen of the periosteum. 63
µm: Woven fibers give way to wavy fibers inside the marrow space (red triangle).
Cortical bone (cb) shows a uniform second harmonic signal with the exception of bright
streaking at insertion sites of collagen fibers from the marrow space into bone. 82 µm:
Wavy fibers within the marrow space, surrounded by cortical bone (cb). 109 µm: Bundles
of collagen fibers insert in collagen bone (red arrow). Fibers bundles (red arrows) are
placed at regular intervals along the marrow wall.
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Figure 3-7 | Second harmonic generation by a collagen-hydroxyapatite scaffold. Top
row: Individual slices taken from the top to bottom of a z-stack. Bottom row: Isometric,
top view and bottom view of a three dimensional reconstruction of the z-stack presented
above.

3.3.3

Tissue-engineered defect repair

At four and six weeks post-implantation of a scaffold seeded with BMSCs, animals were
observed with 2-photon microscopy (Fig. 3-1b). Two locations were examined in each
animal: an area in the central part of the implant and at the edge of the defect. At week
four, in the central part of the defect, a woven layer of collagen containing weakly
expressing Col3.6cyan host cells with spindle-shaped morphology surrounded the
implant on the top surface (Fig. 3-8d, panel 2). Host cell density was high in this layer
above the defect. Relatively few donor cells were observed in this fibrous layer.
Underneath the fibrous layer, scaffold and donor cells were visible (Fig. 3-8d, panel 4-6,
supplementary movie). Due to it’s spectrally broad autofluorescence, the scaffold
appeared whitish in color, distinguishable from cells and the second harmonic signal (Fig.
3-8d, red arrows). A second harmonic signal similar to that observed in native bone was
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observed overlying the scaffold surface, suggestive of collagen in new mineral. The
apposition rate of this layer on the scaffold surface was 0.69 +/- 0.48 µm/day (n=3, in one
sample the implant was completely resorbed). Bright Col3.6topaz donor cells with
osteoblastic cuboidal morphology populated the scaffold region, with some cells fully
embedded in the new layer covering the scaffold surface. Donor cell density appeared
moderate, with clusters of cells overlying the second harmonic layer indicative of new
mineral. At the perimeter of the host bone four weeks after implantation, again a layer of
host cells populated a fibrous layer above the scaffold and host bone. Similar to the
central defect region, a few donor cells were visible in the fibrous layer (Fig. 3-8e). In
contrast to more disparate clustering of donor cells in the implantation site, host cells
formed a dense layer of bright Col3.6cyan osteoblasts on the surface of the host bone.
Host cell density and cell-cell contact appeared to be greater on the surface of host bone
than donor cells on the scaffold in the central defect region (Fig. 3-8d & 3-8e, panel 4 and
below). This dense layer of host cells appeared to be depositing new mineral on the edge
of host bone towards the central implant region (Fig. 3-3). The mineral apposition rate
calculated from the thickness of the new mineral layer and the time since implantation
was 1.88 +/- 0.13 µm/day (n=2, the edge of the original defect was not visible in the other
samples). Some host cells were observed embedded in mineral behind the mineralization
front. These results indicate bone formation had occurred on the scaffold, predominantly
by donor cells, and on the host bone, predominantly by host cells, at four weeks postimplantation.
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Using the pattern of the scaffold network as a guide, we returned to the same central
defect location two weeks later (Fig. 3-9, compare two rightmost columns, arrows
indicate identical features). At week six, additional mineral was deposited in the implant
center indicated by a large increase in the second harmonic layer, indicative of collagen
within mineral (Fig. 3-9, compare two rightmost columns). Furthermore, scaffold near
the top surface was removed (Fig. 3-9, compare two leftmost columns, stars indicate
identical locations), while deeper down, scaffold was retained in mineral. Vertical canals
were visible within the second harmonic surface labeled with alizarin complexone (Fig.
3-9b, rightmost panel, white triangle). The colocalization of red mineral label to the
second harmonic layer covering the scaffold confirms this tissue is indeed mineralized
(Fig. 3-9b, two rightmost panels). From four to six weeks, donor cell density appeared
reduced in two animals, while it remained similar in one animal. Bright Col3.6cyan host
cells were observed on the mineral surface in the animal that retained moderate cell
density. Taken together, these results indicate an increase in mineral deposition from four
to six weeks and provide evidence of site-specific scaffold removal.
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After imaging at week six, calvaria from both the imaged and control group (no imaging
or surgery) were harvested, X-rayed, and cut into thin sections. By examining the X-ray
micrographs, better integration of the implant with host bone was observed in the control
group than the test group (Figs. 3-11a, b & c). However, by histomorphometry, the area
fraction of bone that formed in the defect was similar between the two groups (Figs. 311d, e & f). The resultant bone formed a core-shell architecture. Hematopoietic cells were
observed in the core region (Fig. 3-10), suggesting the marrow space was functional.
Col3.6 osteoblasts were visible lining the inside and outside of the cortical shell (Figs. 311d & e). These data indicate that imaging surgery to expose the calvarium has a negative
effect on host integration, but did not prohibit bone formation.

Figure 3-10 | Bone marrow in implant is functional. Megakaryocyte (white arrow)
shedding RBCs (black arrow) in the bone marrow formed within the implant.
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Figure 3-11 | Imaging surgery affects host integration, but new bone formed is
similar. (a) X-ray of calvarium in imaged group and (b) control group. (c) Radiopacity as
a function of distance from the edge of the defect for control and imaged group (n=3). (d)
Histological section of defect from imaged group and (e) control group. Donor cells
(green), host cells (blue) and mineral label (red). (f) Bone area fraction in the defect
region. Horizontal lines indictate the mean value for each group. The plus sign represents
the sample that did not form bone in the time preceding imaging and was therefore
excluded from the calculation of the mean.

3.4

Discussion

2-photon microscopy combined with transgenic reporter animals has enabled researchers
to observe, in vivo, the spatial and temporal dynamics of cell turnover during bone
homeostasis and regeneration,60 and single transplanted hematopoietic progenitor cells as
they engraft in the bone marrow.106,134 We have established a live-animal imaging model
of tissue engineered bone using 2-photon microscopy and transgenic reporter animals.
Using this approach, we examined host cells, donor cells, scaffold, and collagen matrix in
vivo during a tissue-engineered repair. Following the implantation of a collagen66

hydroxyapatite scaffold seeded with bone marrow cells, we observed the in vivo outcome
four and six weeks after implantation. New bone had formed on the surface of the
scaffold primarily by donor-derived osteoblasts carrying the Col3.6topaz reporter at four
weeks post implantation (Fig. 3-8d, panel 5). This indicates that a sufficient number of
donor cells survived transplantation and went on to form a major contribution to
osteogenesis in the repair site. This finding recapitulates Yu et al., who found
transplanted Col3.6cyan calvarial osteoprogenitor cells survived and formed new bone in
a calvarial defect filled with a collagen-hydroxyapatite scaffold.89 Additionally, Cowan et
al., using X-Y chromosome detection, found donor cells contributed 84-99% of new bone
at 8 weeks following implantation.64

An important question in bone tissue engineering is how does the host contribute to
repair? In the present study, an outer layer of host cells with fibroblastic morphology
encapsulated the implant in collagen fibers. These cells were weakly expressing the
Col3.6cyan reporter and may later contribute host osteoblasts to the implant. Host
Col3.6cyan cells were found on the mineral layer surrounding the scaffold at both week
four and six, albeit at a much lower incidence than donor Col3.6topaz cells. Park et al.,
using live animal 2-photon microscopy, found that Mx1 osteoprogenitor cells rapidly
filled a calvarial microfracture (<1 mm diameter) and differentiated into osteoblasts at the
bone edge.60 In the present study, fibroblastic host cells stemmed from the periosteal
surface of the host calvarium, seen by histological examination (data not shown). The
periosteum is a well-known contributor to fracture repair of long bones.148 Due to
orientation of the imaging plane, 2-photon microscopy enabled unprecedented
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observation of the new periosteal layer formed by the host above the cell-scaffold
construct, likely by a similar osteoprogenitor population found by Park et al.

An increase in mineral deposition indicated by the second harmonic signal was observed
between four and six weeks post-implantation. Additionally, it appeared that the scaffold
near the top surface was resorbed (Fig. 3-9, 48 & 98 µm). This may be due to cellmediated proteolytic degradation of type I collagen fibers in the scaffold by matrix
metalloproteinases, namely MMP-1.93,149 By contrast, scaffold deeper inside the implant
was embedded in mineral and persisted for the duration of the experiment (Fig. 3-9, 131
& 152 µm). The mineral and cellular organization in the scaffold at week six is likely an
intermediate stage before the bone is more fully remodeled. Thus, the embedded scaffold
would only be removed after substantial remodeling of tissue-engineered bone. Yu et al.
found that scaffold structure influences the structure of newly formed bone.89 We found
matrix being directly deposited on the scaffold structure until the pores were filled.
Vertical channels were also noted in the new cortical layer produced at six weeks. These
channels presumably link blood vessels from outside the implant to the implant core.
Live

animal

microscopy

enabled

high-resolution

examination

of

implant

microenvironments at two time points, showing new mineral apposition and scaffold
remodeling. This approach could provide new insights on how other scaffold materials
are degraded and how mineral is deposited on scaffold surfaces.

Differences in cell organization and density were observed between host cells on the
defect edge and donor cells on the mineral surface surrounding the scaffold. At the edge

68

of the host bone, Col3.6cyan host osteoblasts formed a dense layer of cells that formed
bone inward towards the implant. In contrast, donor cell density on the scaffold surface
appeared more moderate with disparate clusters of cells. Additionally, the mineral
apposition rate appeared to be greater at the host edge than in the scaffold region. More
robust measurement of mineral apposition is needed, however, this would suggest that
tissue engineered bone formation is lagging behind host osteogenesis.

In the imaged group there was lower scaffold-host integration. This may be due to
additional inflammatory signals introduced as a byproduct of the imaging surgery.
However, the amount of bone in the defect area was similar (Fig. 3-11d,e,f), and bone
continued to form beyond the four-week time point as shown by the increase of second
harmonic signal in Fig 3-9 (two rightmost columns). This suggests that despite the
imaging surgery, the processes essential to osteogenesis are preserved. Therefore,
important questions that exist within the bounds of osteogenesis, regarding angiogenesis,
scaffold degradation, cell signaling, proliferation and differentiation, may be addressed
with this method. In combination with fluorescent reporters, any genetic entity of interest
may be examined in vivo during bone formation in a cell-seeded construct. By enabling
researchers to probe osteogenesis in vivo, 2-photon microscopy combined with
fluorescent reporters should improve our understanding of the mechanisms that drive
bone healing in a cell-scaffold construct.

In the future, new techniques and improved optics may enable imaging noninvasively
through the skin. Recently, Tang et al. has enabled significant improvements in imaging
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depth of multiphoton microscopy by active compensation and reduction of light
scattering in thick heterogeneous tissue.150 In their work, they imaged completely through
a mouse skull to visualize fluorescent beads under the bottom surface. Although this
method is currently limited to small fields of view (~10 µm), implementing image
reconstruction algorithms should bring in vivo imaging to new depths within an
arbitrarily large field of view. Additionally, the use of longer wavelength excitation (near
infrared), corresponding to less light scattering, should also extend the maximum depth of
2-photon imaging systems. However this also depends on the development of probes
capable of far-red excitation. Thus, future examination of cells in bone and bone defects
may be performed noninvasively, eliminating imaging surgery and associated effects.

3.5 Conclusion
In summary, we have evaluated tissue-engineered bone in vivo at single cell resolution
and in situ in three dimensions at two time points in the same animals. Using skeletal
lineage reporters, we have described the tissue microenvironment preceding a repair
study and enabled the connection between stereomicroscopy, histology, and 2-photon
microscopy. In doing so we have also described the collagen organization in calvarial
bone and marrow space. Lastly, we have revealed a window into the dynamic progression
of a tissue-engineered construct in vivo, previously unseen. In this view we have made
observations of donor cells, host cells, scaffold, and collagen organization in the repair
site. Visualizing the cell and biomaterial interactions that govern the regeneration process
in vivo should contribute to the development of tissue engineering therapies that
efficiently utilize donor cells and cooperate with host response.
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4
Bone tissue engineering with a collagenhydroxyapatite scaffold and culture expanded bone marrow
stromal cells

4.1

Introduction

Cell-based tissue engineering of bone has shown promising clinical62 and
preclinical64,65 results, however, this approach is not yet well understood and faces
several challenges before becoming a transformative clinical procedure. One such
challenge is the delivery of progenitor cells in a supportive biomaterial that provides the
microenvironmental cues for cell survival, vascular invasion, and bone formation.
Additionally, the biomaterial scaffold must be degradable, leaving only new tissue behind
when the repair is complete. Thus far, an ideal scaffold for bone tissue engineering has
not been identified.68

Bone is primarily composed of hydroxyapatite [Ca10(PO4)6OH2] (~69% by weight)
substituted with ions such as carbonate and magnesium.6,7 Type I collagen forms ~90%
of the organic fraction of bone, with the remaining ~10% being proteins such as
osteonectin, fibronectin, and osteopontin, among many others.6 Following a biomimetic
design paradigm, we have developed a type I collagen-hydroxyapatite scaffold (herein
termed Col-HA).92 The type I collagen phase is easily degraded by cell-secreted
collagenases, supports differentiation of progenitor cells into bone forming
osteoblasts,89,92 and contains unique binding motifs for the attachment of other ECM
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molecules such as fibronectin151. Additionally, the degradation of collagen into gelatin
may provide a means for cells to modulate the availability of RGD sites, normally hidden
within the collagen triple helix.152

Several collagen-calcium phosphate materials are currently FDA-approved for use with
bone marrow extract as a bone void filler, such as Healos® (Depuy), Collagraft®
(Zimmer), Ossimend® (Collagen Matrix), and Mozaik® (Integra LifeSciences). However,
osteoprogenitors represent only a very small fraction of the bone marrow population,37
and it has been found previously that the number of progenitors strongly influences
osteogenesis in vivo.153 One study has indicated that fresh bone marrow combined with a
coral scaffold did not form bone when implanted in a ovine segmental defect, whereas
culture-expanded bone marrow stromal cells (BMSCs), seeded to the same material, did
form new bone.65 Thus culture expansion, which greatly increases the number of
osteoprogenitors, is a likely requirement for successful cell-based bone tissue engineering.
Currently, there is no clinical precedent for the use of commercial collagen-HA scaffolds
with culture-expanded osteoprogenitors.

Commercial scaffolds are useful for the development of cell-based therapies for bone
tissue engineering, due to their sterility, use-history, and consistency. However design
modifications by the researcher are generally out of reach. Additionally, in order to
understand how scaffold properties influence cell-based outcomes it would be of benefit
to the researcher to have full control over scaffold properties. This would ultimately
allow for a deeper understanding of cell-scaffold interactions, ultimately leading to

72

optimal scaffold design and contributing to the long-term goal of safe and efficient cellbased therapies in the clinic.

The goals of this work were to (i) fabricate a sterile collagen-HA scaffold (ii) evaluate
cell attachment, viability, and progenitor number in the scaffold just prior to implantation,
(iii) achieve consistent osteogenesis in vivo with the Col-HA scaffold combined with
culture-expanded BMSCs, and (iv) compare the level of early bone formation in the ColHA scaffold to an established commercial collagen-HA biomaterial. The Col-HA
scaffold presented here supports robust osteogenesis and is fully defined, open, and
modifiable. This platform is ideal for basic research and facilitates the development of
collagen-hydroxyapatite biomaterials for bone tissue engineering.

4.2

Materials & Methods

4.2.1 Scaffold fabrication by collagen-hydroxyapatite co-precipitation and freeze
casting
The main component of the scaffold, type I collagen, was derived from rat tail tendons
following Rajan et al.154 Collagen fibers and HA nanoparticles were formed
simultaneously by precipitation in a modified simulated body fluid (mSBF) solution.91
Briefly, the collagen solution was adjusted to 2.5 mg/mL by a two-fold dilution in sterile
ultrapure water at 4 °C. For a 200 mL solution of mSBF, the following salts were added
in the order they appear: 1.08 g NaCl, 0.1428 g K2PO4, 0.0622 g MgCl2, 2.4 g HEPES,
0.1758 g CaCl2, and 0.294 g NaHCO3. While kept cold, the pH of the solution was
adjusted to 7.0 with sodium hydroxide solution and then transferred to a water bath at
40 °C for 24 hours to allow in situ co-precipitation. The gel-precipitate was centrifuged at
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11,000 g and 4 °C for 12 min. The supernatant was discarded and the pellet was freeze
dried (Labconco). The collagen-HA precipitate was reconstituted with water at a
concentration of 100 mg/mL, briefly homogenized to obtain a uniform slurry, and placed
in a polystyrene culture dish. To impart a porous structure, the sample was freeze-dried
starting from room temperature to -40 °C at a cooling rate of -0.37 °C/min. The dried
scaffold

was

immersed

in

a

solution

of

20

mg/mL

EDC

[1-ethyl-3-(3-

dimethylaminopropyl) carbodiimide hydrochloride] for 24 hours at 4 °C to covalently
crosslink the collagen fibers. The scaffold was then rinsed in a solution of 5% (w/w)
glycine in sterile water overnight to block unreacted EDC, followed by three sequential
rinses in sterile water for 15 minutes each at 4 °C. Finally, rinsed scaffolds were freezedried again, cut to a thickness of ~500 µm with a milling machine and punched to a
diameter of 3.5 mm.

Healos® is composed of bovine type I collagen fibers mineralized with a thin coating of
calcium phosphate, and formed into a high porosity sponge containing 4-200 µm pores.
This material was received sterile. In house scaffolds were terminally sterilized with a 24hour exposure to ethylene oxide gas using a bench-top sterilizer (Anprolene AN74i,
Anderson Products), followed by a 24-hour purge of excess gas in a vented hood. Before
implantation, sterility of Col-HA scaffolds was assessed by incubating sterilized and
unsterilized scaffolds, a negative control, in Tryptic Soy Broth (Sigma) at 40 °C for 2
weeks. The sterility of the scaffold was confirmed by the absence of bacterial growth in
vials containing ethylene oxide sterilized scaffolds under these culture conditions.
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4.2.2

Characterization of collagen-hydroxyapatite scaffold

The ratio of inorganic (HA) to organic (collagen) content was determined by
thermogravimetric analysis (TGA Q-500, TA Instruments). The inorganic material was
examined by X-ray diffraction (D2 Phaser, Bruker) performed on the resultant powder
from a proteinase-K (Invitrogen) digestion of the scaffold. Diffraction peaks were
acquired from a 2Ө of 10° to 90° at a scan speed of 2.4 °/min.

Infrared absorbance spectra from 4000 to 400 cm-1 was acquired at a resolution of 4 cm-1
over 32 scans (Magna 560, Nicolet). Spectra were then analyzed with KnowItAll V9.5
software (BioRad).

Electron micrographs were acquired with a field emission scanning electron
microscope (JSM-6335F, JEOL). Prior to imaging, Col-HA scaffolds were sputter-coated
(Polaron E5100) with a thin layer of gold-palladium.

To enable examination of scaffolds with X-ray tomography, scaffolds were stained with
1% iodine in ethanol overnight to enhance radiopacity.155 1500 images were acquired at
an angle of -103˚ to 103˚ with an exposure time of 4 s, source power of 8 W, a voltage of
55 kV, and a 20x objective (MicroXCT-400, Xradia). Tomography images were
reconstructed with XM Reconstructor (Xradia) and viewed with the 3D viewer plugin for
the FIJI distribution of NIH ImageJ.142
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Scaffold porosity, wall thickness, and anisotropy were calculated from tomography data
from dry scaffolds with the BoneJ plugin for FIJI.156 Since very small pore interconnects
may result in a near 100% interconnectivity, but have minimal contribution to mass
transport, we excluded pores with a size less than 15 microns from the interconnectivity
measurement. This was accomplished by performing a sphere-filling algorithm (thickness,
BoneJ)156 to the void volume. A threshold was then performed to select the fraction of the
void volume with a caliber from 0-15 µm. This was added to the original solid structure
to fill the small holes (≤15 µm) in the scaffold walls. Finally, the interconnectivity
(connected void volume/total void volume) was calculated using the 3D objects
counter157 applied to the void volume. The largest object was used as the interconnected
volume.

Scaffold pore size was determined from histological sections of the scaffold using the
mean linear intercept method.158 Briefly, transverse sections of scaffolds were obtained
by cryosectioning (CM3050 S Cryostat, Leica) and imaged with darkfield optics (Axio
Scan.Z1, Zeiss). Image processing was performed with ImageJ. Four sections were
analyzed by drawing four lines regions of interest (ROIs) at different orientations for
each section. The mean pore size was calculated as an average of the pore lengths falling
on the line ROIs.

Scaffold permeability, k (m4/Ns), was measured with water and a custom flow cell using
the following equation found in reference 159:
𝑘=

∆𝑥
2𝜋 ! 𝑟 !
∙
𝐴 ∙ 𝑀!! (𝑀!! 𝑀!! )! − 1
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where, ∆𝑥 = scaffold length (m), A = scaffold cross-sectional area (m2), MB1 = mass flow
rate without scaffold (g/s), MB2 = mass flow rate with scaffold (g/s), and r = radius of the
outlet (m).

4.2.3

In vitro cell culture with primary mouse osteoprogenitors

Mouse BMSCs were isolated from the femur and tibia of CD1 wild type animals. Cells
were added to 100 mm culture dishes in α-MEM (Gibco) containing 10% fetal bovine
serum and 1% penicillin-streptomycin. Following isolation, cells were allowed to attach
to the culture dish in a humidified incubator at 5% CO2, ambient O2 and 37 ˚C. To allow
hematopoietic cells to contribute to early colony formation by osteoprogenitors, the
culture medium was changed four days after seeding the bone marrow pellet. After six
days of incubation, cells were trypzined and seeded dropwise onto the top of either the
Col-HA scaffold or a bovine collagen-hydroxyapatite scaffold (Healos®, Depuy) at a
density of 1.0x106 cells in 15 µL of culture medium to immerse the scaffold. After
seeding, cells were allowed to settle for 30 minutes before an additional 1 mL of culture
medium was added to the culture well. Cell permeation and attachment were assessed at
one minute, one hour, and 12 hours after seeding. Cell-seeded constructs were also
incubated for a one-week period to evaluate cell attachment, distribution, and to check for
dramatic scaffold degradation associated with the sterilization method.

Following in vitro incubation, scaffolds were fixed in 10% formalin and stained for Factin (Rhodamine-Phalloidin, Invitrogen) and nuclear DNA (Hoescht, Invitrogen). Cell
viability and progenitor status was examined after one and five days of in vitro incubation.
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Viability was assessed using calcein and ethidium homodimer-1 provided as a kit
(Live/Dead, Invitrogen). Osteoprogenitor cells were labeled using the α-SMAAmCherry
fluorescent reporter. This reporter marks a population of multipotent cells and consists of
a transgene containing the mCherry fluorescent protein driven by the smooth muscle
alpha actin (α-SMA) promoter. 41

To enable viewing of the scaffold cross-section, the scaffold was cut in half and glued
to the bottom of a culture well, with the cross-section facing up. The cross-section of the
scaffold was scanned in three-dimensions to a depth of 100 µm with a 2-photon
microscope (Ultima IV, Prairie technologies). Several tiles were stitched together to form
a high-resolution (20x objective) wide field view. Second harmonic images were
acquired at an excitation wavelength of 900 nm and data was collected at 450 nm,
corresponding to the frequency doubling of the excitation wavelength as it interacts with
the noncentrosymmetric structure of the collagen triple helix.113

4.2.4

Image processing and analysis of in vitro data

Cell distribution from the outside edge was assessed by a distance analysis.106 The cell
seeding efficiency (CSE), defined as the number of cells in the scaffold divided by the
total number of cells seeded, was calculated using the 3D particle counter to identify and
count cell nuclei in 3D stacks of seeded scaffolds.

4.2.5

In vivo bone formation in a mouse calvarial defect
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Two groups (n=5) of NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) immunodeficient mice
were used as hosts. One day after scaffold seeding, host mice were anesthetized with a
ketamine (135 mg/kg) – xylazine (15 mg/kg) blend and a 3.5 mm diameter critical size
defect was created in the right parietal lobe using a bur trephine (RAL #229-030, Benco
Dental). Extreme care was taken to prevent damage to the dura mater beneath the
calvarium. Animals were given postoperative analgesic (bupronephrine, 0.08 mg/kg). At
three weeks post-implantation, animals were sacrificed for X-ray and histological
analysis. To mark areas of active mineralization, calcein and alizarin complexone labels
were injected intraperitoneally at two and three weeks, respectively.
In order to track cell fate after transplantation, donor cells were derived from bone
marrow from CD1 animals carrying a Col3.6Cyan reporter gene. The reporter consists of
the cyan fluorescent protein driven by a type I collagen promoter region that is activated
in osteoblasts.43 The bone marrow was flushed with a 27-gauge needle from the femur
and tibia of CD1 Col3.6Cyan animals and plated in α-MEM (Gibco) containing 10% FBS
and 1% penicillin-streptomycin, incubated at 37 ˚C, 5% CO2, and ambient O2. After 6
days, adherent cells were removed with 0.25% trypsin-EDTA (Gibco). One million cells
in 15 µL of culture medium were seeded dropwise to each dry Col-HA and Healos®
(Depuy) scaffold. After seeding, cells were allowed to settle for 30 minutes before one
mL of culture medium was added. Cells were incubated with scaffolds overnight to
ensure full cell attachment to the scaffold surface. All procedures in this study were
approved by the UConn Health Center Institutional Animal Care and Use Committee
(IACUC).
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4.2.6

Histomorphometric analysis of in vivo data

To quantify the bone area fraction and donor cell area fraction for the test and control
group, a region of interest (ROI) outlining the defect area was manually drawn on
radiographs and histological sections. A threshold was then applied to the images to
demarcate areas of bone.

To evaluate the edge integration of the constructs from radiographs, a line ROI was
manually drawn along the perimeter of the implant, but inside the defect area. The line
ROI contains the peripheral regions of the implant that were contacting host bone. If the
implant was connected to the host bone, this would appear as a bone pixel in the line ROI
placed between the construct and the edge of the host bone. To find the fraction of the
host bone perimeter that was connected to the implant by bone, the number of bone pixels
was divided by the total number of pixels in the line region.

Donor cell colocalization with the mineral label was determined using the distance
analysis mentioned in the in vitro image analysis section. To exclude donor cells not
associated with the label surface, a cutoff value of 14 µm was applied, corresponding to
the mean distance from the edge of the label surface to the far edge of a donor cell on the
label surface.

4.2.7

Statistical analysis

A t-test was used to determine statistical significance (p<0.05) between the Col-HA and
Healos® groups (n=5).

80

4.3

Results

4.3.1

Characterization of the collagen-hydroxyapatite scaffold

Following freeze casting, the scaffold contained 15.36% water, 60.94% collagen, and
23.70% HA by thermogravimetric analysis (Fig. 4-1). The identity of the inorganic phase
was confirmed as HA by analysis of the XRD pattern of the resultant powder following
proteinase-K digestion of the collagen-HA composite (Fig. 4-2f). The XRD pattern was
indicative of a poorly crystalline HA with broad peaks, namely at a 2Ө of 25.9˚ and 31.8˚
corresponding to the (002) plane, and overlap of the (211), (112), and (300) planes of HA,
respectively.

FT-IR absorbance spectra of the digested scaffold sample further indicated that the
inorganic phase is a carbonated HA, sharing similarities with the absorbance spectra of
hydroxyapatite from dentin (Fig. 4-2g). Phosphate vibrational bands were observed at
961 (ν1), 475 (ν1), 1046 (ν3), 603 (ν4), and 567 (ν4) cm-1.160 Carbonate vibrational bands
were observed at 873 (ν2) and 1400-1580 (ν3) cm-1.161 Amide I and Amide B bands from
residual collagen in the sample were detected at 1653 and 2923 cm-1, respectively.161
Taken together, these results indicate the inorganic phase of the scaffold is a poorly
crystalline carbonated hydroxyapatite similar to that found in native bone.

81

Figure 4-1 | Thermogravimetric analysis of collagen-HA scaffold.
The collagenous phase of the scaffold produced a strong second harmonic signal when
examined with 2-photon microscopy (Fig 4-2h-j). Since the second harmonic signal from
collagen is due to the repeating noncentrosymmetric structure of the triple helical
protein,113 this indicates the scaffold contains collagen in a triple helical conformation
rather than a denatured conformation (gelatin) which does not produce a second harmonic
signal.120

The scaffold microstructure has a cellular organization with sheet-like walls (Fig 4-2a,
4-2c, 4-2d). Near the nanoscale, the scaffold structure consists of agglomerated HA
nanoparticles interspersed within collagen fibers (Fig. 4-2b). By X-ray microtomography,
the porosity of the scaffold was found to be 93% (Table 2). The mean pore size was
101±71 µm, with a scaffold wall thickness of 5.5±2.4 µm (Fig. 4-2d). Pore alignment was
largely isotropic with an anisotropy value of 0.3 (one being a perfectly aligned structure
and zero being random). The scaffold permeability and degree of interconnectivity was

82

1.68×10-10 m4/Ns and 99%, respectively (Table 2). This scaffold architecture and
composition should be supportive of cell infiltration, attachment, and osteogenesis.
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Figure 4-2 | Characterization of Col-HA scaffold. (A) Electron micrograph of a ColHA scaffold cut in cross section. (B) Magnification of hydroxyapatite nanoparticles
(white arrow) interspersed with collagen fibers (red arrow). (C) 3D reconstruction of the
scaffold acquired by X-ray microtomography. (D) 3D reconstruction of the scaffold
color-coded to indicate wall thickness. (E) Scaffold pore volume in 3D acquired by X-ray
microtomography. (F) X-ray diffraction pattern of the inorganic phase of the scaffold
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compared with a hydroxyapatite reference (vertical bars). (G) Infrared absorbance spectra
of the inorganic phase of the scaffold (black line) compared with a hydroxyapatite
reference spectra (red line). (H) A single slice of a 3D stack of images representing the
collagen-HA scaffold imaged by its second harmonic signal. (I) Top and (J) isometric
view of a 3D reconstruction of the collagen-HA scaffold viewed with second harmonic
microscopy.

Sample

Porosity
(%)

Pore size
(µm)

Wall thickness
(µm)

Interconnec
tivity (%)

Permeability
(m4/Ns)

Anisotropy

0.3
Col-HA
93
101±71
5.5±2.4
99
1.68×10-10
Table 2 | Scaffold architectural properties. The interconnectivity is defined as the
connected void volume divided by the total void volume. The value of the anisotropy
parameter tends toward zero for randomly oriented structures and to one for parallel flat
plates.

4.3.2

Cell seeding and attachment to collagen-hydroxyapatite scaffolds

To evaluate the time required for culture-expanded mouse BMSCs to attach to the
scaffold, cells were seeded to Col-HA scaffolds and Healos®. Subsequently, scaffolds
were harvested at one minute, one hour, and 12 hours after seeding. It was found that
cells were well-attached after 12 hours of in vitro culture, but not within one hour or, not
surprisingly, within one minute (Fig. 4-3a-f). The one-minute condition represents the
initial conditions at the time of implantation when cells are seeded to a scaffold and
immediately implanted.

Cells were present throughout the thickness of both scaffolds at all time points,
indicating cells were able to penetrate through interconnections in the void volume (Fig.
4-3a-f). However, cell density decreased with increasing distance from the outer surface
of the scaffold (Fig. 4-3g). The cell seeding efficiency was found to be ~10% when the
initial seeding number was one million cells. This corresponds to about 100,000 cells
seeded to a scaffold, prepared in the geometry of a 3.5 mm diameter mouse critical-size
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calvarial defect. Furthermore, large clumps of cells on top of the scaffold were observed
at one minute and one hour after seeding (Fig. 4-3a,b, & Fig. 4-4). In a separate
experiment, these clumps were not present after a few weeks of implantation,162
suggesting that these cells do not survive after implantation. Similarly, cell clumping on
the loading side of the scaffold was not observed after 12 hours of in vitro culture,
indicating that unattached or poorly attached cells may not survive beyond a few hours.
These results indicate that a 12-hour incubation time is sufficient for culture-expanded
mouse BMSCs to fully attach to the scaffold. To ensure cell attachment before
implantation, a 12-hour incubation period was used in all experiments described hereafter.
Sterilizing protein-based biomaterials is challenging due to the potential for material
damage as a result of the sterilization process. Immersion in 70% ethanol is not a robust
sterilization method, since hydrophilic virus and bacterial spores are resistant to this
method.163 Previously, we observed rapid degradation of our scaffolds (< one week)
when sterilized with gamma irradiation and cultured with mouse BMSCs (data not
shown). Herein, ethylene oxide gas was employed to sterilize Col-HA scaffolds. Sterility
was confirmed by the absence of bacterial growth after two weeks in bacterial culture
medium at 40 °C.
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Figure 4-3 | In vitro characterization with mouse BMSCs. Maximum intensity
projections of scaffolds cut in half and imaged in 3D normal to the cross-section. Healos
scaffold after (A) one minute, (B) one hour and (C) 12 hours of incubation with mouse
BMSCs. Col-HA scaffold after (D) one minute, (E) one hour and (F) 12 hours of
incubation with mouse BMSCs. The collagen content generates a second harmonic signal
(cyan). Cells were stained for F-actin (yellow) and nuclei (punctate cyan signal). (G)
Quantification of cell distribution relative to the outside edge. (H) Cell seeding efficiency
at one minute, one hour, and 12 hours of incubation after seeding (initial seeding density
was 1 million cells/scaffold, approximately 3.5 mm in diameter and 500 µm thick).
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Figure 4-4 | Cell clumping on scaffold. Maximum intensity projection of a 2-photon
stack acquired in a cross-sectional view of a Healos® scaffold. Cells are stained for Factin (yellow), nuclei (cyan) and the scaffold produces a second harmonic signal (blue).
To determine if the sterilization procedure had a negative effect on scaffold degradation,
as observed with irradiation sterilization, scaffolds were cut into disks and seeded with
culture-expanded mouse BMSCs and incubated for one week. In contrast to gamma
irradiation (data not shown), ethylene oxide sterilized scaffolds did not exhibit rapid
degradation when cultured with cells for one week (Fig. 4-5). The Col-HA scaffolds
maintained their original circularity, while the Healos® control group expanded
anisotropically upon hydration (Fig. 4-5a-d). When stained for F-actin filaments after 1
week in vitro, cells were well attached to the scaffold surface and distributed throughout
the thickness (Fig. 4-5e-g). These results suggest ethylene oxide is a suitable method for
producing sterile collagen-hydroxyapatite scaffolds without resulting in rapid degradation
(<1 week in vitro) and maintaining good cell attachment to the biomaterial.
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Figure 4-5 | Sterilized scaffolds seeded with mouse BMSCs after one week in vitro.
(A) Ethylene oxide gas-sterilized Col-HA scaffold, and (B) Healos® after one week in
vitro with mouse BMSCs. Quantification of the (C) aspect ratio (long axis/short axis) and
(D) longest diameter (Feret’s diameter) Col-HA and Healos® scaffolds after 1 week in
vitro. Maximum intensity projection of (E) a Col-HA and (F) a Healos® scaffold seeded
with mouse BMSCs cut in cross-section after one week in vitro. (G) Maximum intensity
projection of a 2-photon stack acquired from a top view of a Col-HA scaffold. Cells (E)(G) are stained for F-actin (yellow), nuclei (cyan), and the scaffold produces a second
harmonic signal (blue).
Previous work has indicated that the BMSCs from the donor population are
predominantly responsible for bone formation in the calvarial model.64,89,162 This
observation underscores the need for a viable progenitor population within the seeded
scaffold to achieve consistent osteogenesis. Here, we examined the cell viability and the
distribution of osteoprogenitor cells at one and five days after seeding Col-HA scaffolds.
At day one, the majority of cells were viable, however, cells were not uniformly
distributed in the radial direction of the scaffold (Fig. 4-6a). By contrast, at day five, cells
were well distributed throughout the scaffold (Fig. 4-6b), highlighting the ability of cells
to migrate into available space. Upon closer inspection with 2-photon microscopy, a
subset of smaller diameter nonviable cells was found within the scaffold walls (Fig. 4-6e).
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To examine cell viability throughout the thickness of the scaffold, samples were cut in
half and viewed in cross-section. Cells appeared predominantly viable throughout the
scaffold thickness five days after seeding (Fig 4-6f), suggesting that strictly diffusive
transport in the relatively thin scaffold is sufficient to support cell viability over this
period. Similarly, when cells containing a fluorescent marker for osteoprogenitor cells, αSMAAmCherry41, were seeded to Col-HA scaffolds, they were not homogenously
distributed by day one (Fig. 4-6c), but were homogenously distributed by day five after
seeding (Fig. 4-6d). Taken together, these results suggest that at one day after seeding,
representing the initial conditions at the time of implantation used here, cells were well
attached to the scaffold, viable, and the population contained large numbers of
osteoprogenitors.
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Figure 4-6 | Cell viability and progenitor status. Col-HA scaffolds seeded with culture
expanded mouse BMSCs and incubated for (A) one and (B) five days in vitro. Scaffolds
were stained for live (green) and dead (red) cells. (A slight red background is visible, due
to scaffold adsorbance of the dead stain). Col-HA scaffolds seeded with culture expanded
mouse BMSCs carrying a SMAAmCherry (red) reporter for osteoprogenitor cells and
incubated for (C) one and (D) five days in vitro. (E) Single image of a 2-photon
micrograph showing live (green) overlying the scaffold (blue) and smaller dead (red)
cells that have invaded the scaffold walls after one day in vitro. (F) Maximum intensity
projection of a 3D stack of the scaffold containing cells stained for live (green) and dead
(red) viewed in cross section after five days in vitro.

4.3.3

In vivo calvarial defect model of bone repair

Three weeks after implantation, calvaria containing critical size defects filled with
BMSCs combined with either the Col-HA scaffold or Healos® were harvested. Viewed
with a stereomicroscope (Fig. 4-7), the implant regions were more opaque than the
surrounding host bone. All samples contained bone by radiographic discrimination and
several implants appeared well integrated to the host bone (Fig. 4-8a through 4-8d, and 4-
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8g through 4-8i). Two samples were not well connected to the host bone (Fig. 4-8f, 4-8h,
orange arrows) and two others exhibited significant gaps between the implant and host
(Fig. 4-8e, 4-8j, orange arrows). Some implants appeared to overlap the edge of the host
bone rather than filling the defect (Fig. 4-8e, 4-8g, 4-8h, 4-8i, blue arrows). Since all
scaffolds were placed in the defect at the time of implantation, this would require the
edge of the scaffold to pop out some time after.

Mineralized tissue was observed between the red and green mineralization labels, given
at two and three weeks respectively (Fig. 4-8k, 4-8l, 4-8o, 4-8p), indicating that new bone
had formed as opposed to mistaking the calcium phosphate phase of the scaffold for new
bone. Donor cells carrying the Col3.6Cyan43 osteoblast reporter gene were found lining
the active mineralizing surface labeled with alizarin red (Fig. 4-8l, 4-8p). Furthermore,
75±0.10% and 67±0.05% of the mineral label was lined with donor cells for Healos® and
Col-HA respectively, (Fig. 4-9) suggesting that the donor source played a dominant role
in early bone formation (<3 weeks). Taken together, these results indicate that all samples
contained mineralized tissue deposited primarily by donor cells and that some of the
samples appeared to have degraded.

The mean bone area fraction (AF) from radiographs was slightly higher for the Col-HA
group compared to the Healos group, however this difference was not significant (Fig.
5s). In cross-section, the mean bone AF was similar between the groups (Fig. 4-8t). The
Col-HA scaffolds, when viewed from the top, were slightly more integrated with host
than the Healos® group, however, this result (p=0.077) was not significant (Fig. 4-8u).
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When the mean AF of donor cells in the defects viewed in cross-section was compared,
the Healos® group was slightly higher, although this difference was not significant (Fig.
4-8v). The in-group standard deviation for each of the four parameters investigated was
smaller for the Col-HA group compared with the Healos® group (Fig. 4-8s through 4-8v,
blue bars indicate one standard deviation). Taken together, these results indicate the ColHA group exhibited consistent bone formation and appeared well attached to the host in
four out of five samples. When compared to Healos®, the Col-HA scaffold performed
favorably, providing evidence for the efficacy of the Col-HA scaffold for cell-based bone
repair.

Figure 4-7 | Stereomicroscopy of scaffolds after 3 weeks of implantation in mouse
critical size calvarial defects. Presented in the same arrangement as the radiographs
shown in Fig. 5.
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Figure 4-8 | Evaluation of bone formation within mouse critical size calvarial defects
after three weeks. Radiographs of calvarial defects filled with mouse BMSCs in (A)-(E)
Col-HA and (F)-(J) Healos® scaffolds after three weeks. Blue arrows indicate areas
where the scaffold popped out of the defect. Orange arrows indicate sites of scaffold
degradation. (K) Fluorescence and (M) toluidine-blue stained sections from (K)-(N) ColHA and (O)-(R) Healos® scaffolds. The samples, (B) and (G), from which the sections,
(K) and (O), came are indicated on the radiographs by the red line. Fluorescence images
contain donor cells (cyan), mineralization label delivered at two weeks (green) and one
day before sacrifice at three weeks (red), overlayed on a darkfield image of the
mineralized tissue. Quantification of (S) bone area fraction from radiographs, (T) bone
area fraction from histological sections, (U) edge integration from radiographs, and (V)
area fraction of donor cells from histological sections. (S)-(V) Red line indicates the
mean, pink bars indicate 95% confidence intervals and blue bars indicate one standard
deviation. Individual samples are represented by dots.

Figure 4-9 | Donor cell colocalization to the surface of the mineralization label.
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4.4

Discussion

Biomaterials for cell delivery have enabled considerable progress towards consistent
bone regeneration in defect sites.65,164,165 However, challenges remain, such as cell
survival in the implant88 and realizing the ideal degradation rate of the biomaterial63. We
have developed a type-I collagen-hydroxyapatite scaffold for cell-based bone tissue
engineering that is relatively simple to fabricate, highly porous, and is easily remodeled
by cells. Here we show that this biomaterial retains progenitor cells, supports robust new
bone formation after only three weeks in vivo, and for the metrics and time point
examined here, is comparable in performance to a clinical-grade material (Healos®), used
here as a benchmark. Unlike the commercial benchmark, the Col-HA material is an open
scaffold produced in an academic lab, facilitating further modification and development
of this class of biomaterials towards healing bone defects in a clinical setting with
culture-expanded osteoprogenitors.

The microstructure of the Col-HA scaffold is an interspersed composite of collagen
fibers and HA nanoparticles (Fig. 4-2b), generated by simultaneous collagen
fibrillogenesis and precipitation of HA nanoparticles. By contrast, Healos® is composed
of collagen fibers with a thin coating of hydroxyapatite. The collagen component of the
Col-HA scaffold is arranged in a triple-helical conformation, indicated by second
harmonic imaging (Fig. 4-2h through 4-2k). Cell attachment to collagen has been
reported to be strongly dependent on protein conformation.121,152,166 The availability of
collagen motifs on the scaffold surface may facilitate binding of cells, ECM proteins, and
provide signals to infiltrating cells as the collagen is remodeled.
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Employed here to fabricate the Col-HA scaffold, freeze casting is a relatively gentle
process that accommodates the incorporation of proteins and generates a highly porous
and thin-walled architecture. Due to the compliant mechanical properties of the collagenHA scaffold, it may be best suited for non-loading bearing indications such as
craniofacial repair. However, many bone fractures require fixation in combination with
bone grafting, thus a compliant collagen-HA scaffold could theoretically be applied in a
load bearing application when combined with mechanical fixation. If new bone quickly
fills a defect, it will supersede the poor mechanical properties of the original scaffold, just
as the soft cartilaginous callus becomes rigid bone following normal fracture healing.
Additionally, a more radiolucent biomaterial, such as the Col-HA scaffold, enables better
radiographic discrimination of the progression of new bone formation in a cell-seeded
construct.

Marcacci et al. found that a pure hydroxyapatite scaffold was not fully degraded after 6
years of implantation with culture-expanded BMSCs in humans.63 By contrast, the
collagen-HA scaffold described here can degrade faster (~weeks) than pure
hydroxyapatite scaffolds owing to MMP-mediated degradation of the collagen phase. A
few of the collagen-HA scaffolds tested herein exhibited more rapid degradation (<3
weeks) at the peripheral edge. This type of rapid degradation impairs host integration and
reduces the amount of bone formed. Rapid degradation may result from early MMPmediated degradation of type I collagen by host cells of the innate immune system.167–169
In a separate experiment, it was found that repeated surgery to expose the implant for
live-animal imaging resulted in a similar radial gap between the host and implant,
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whereas a control group that did not undergo additional surgery displayed much better
integration, further pointing to an inflammatory mechanism behind peripheral scaffold
degradation.162 Neutrophil-derived MMP-8 has been reported to act on type I collagen
scaffolds implanted in mouse myocardium.169 Interestingly, when empty scaffolds were
implanted in mouse calvarial defects, scaffolds persist without noticeable degradation
(data not shown), suggesting a dependence on the donor BMSC population for peripheral
scaffold degradation. BMSCs have been shown to play an immunomodulatory role in
vitro and in vivo, with an anti- or pro-inflammatory effect proving at times variable and
strongly dependent on the microenvironment they experience.170,171 One possibility
regarding the samples exhibiting degradation herein, is that the wound microenvironment
experienced by the donor BMSCs did not drive them towards immunosuppression.
Instead, primed by such a milieu, seeded BMSCs could have promoted neutrophil
invasion and MMP-mediated degradation of the scaffold.170

Donor cells were predominantly responsible for bone formation in both groups of
scaffolds, echoing earlier reports.64,89,162 Here we observed Col3.6Cyan donor osteoblasts
overlying a red mineralization label, providing a rigorous indicator that donor cells were
responsible for de novo tissue formation. Since the scaffold is relatively thin (400-500
µm), diffusion of nutrient and waste removal appears sufficient to support cells through
the early period following implantation when a functioning vasculature has not yet
formed. Larger defects will likely require a more advanced vascular plexus prior to
implantation to ensure donor cell survival. The limitations of this study include the
relatively early time frame examined, the non-load bearing model, and the small sample

98

size (n=5). In the future, longer time points in a load-bearing defect combined with
mechanical testing of the functional properties of new bone should be examined to more
critically evaluate this approach.

4.5

Conclusion

We have developed a sterile collagen-HA scaffold for cell-based bone tissue
engineering and examined its material properties and biological performance in vitro and
in vivo combined with culture-expanded mouse BMSCs. The scaffold is composed of
triple-helical type I collagen and poorly crystalline carbonated apatite arranged in a
porous (93%) cellular architecture. When seeded to the scaffold, cells percolate through
the full thickness of the thin geometry (~ 500 µm thick) and are fully attached to the
biomaterial after 12 hours in vitro. The population of seeded cells just before
implantation contained predominantly viable cells and large numbers of osteoprogenitors.
When the Col-HA and control scaffolds were seeded with culture-expanded mouse
BMSCs and implanted into a critical size calvarial defect, robust bone formation was
observed in both groups at three weeks post implantation. For the number of scaffolds
(n=5) and early time point investigated here, quantitative histomorphometry indicated no
significant difference between the Col-HA and control scaffold in terms of bone
formation and donor cell retention. The Col-HA scaffold is an open and well-defined
platform that enables the researcher to have greater control of a cell-biomaterial model
system, facilitating further development of collagen-hydroxyapatite biomaterials for cell
delivery and bone defect repair.
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5
Effects of a cell-attachment period and extracellular
matrix cell on bone formation in vivo with collagenhydroxyapatite scaffolds

5.1

Introduction

Cell-based bone tissue engineering holds promise to supplement or replace the limited
supply of autologous bone for bone grafting procedures. Osteoprogenitors can be sourced
from the bone marrow, expanded in vitro, and seeded to a scaffold to form a bone graft.
Several animal studies using a scaffold combined with bone marrow stromal cells
(BMSCs) have shown encouraging results healing bone defects.65,164,172 This approach
was also tested in a few human patients, and appeared to form new bone when viewed
radiographically.62,63 However, there has been no large-scale clinical trial of cell-based
bone tissue engineering as of yet, and this approach has lagged behind growth factor
based-approaches.66 Negative side effects have been observed in connection with the
delivery of a single morphogenetic factor, which requires very high doses to be
effective.77 By contrast, cells produce hundreds of factors during healing, and a cellbased approach could sidestep limitations regarding side effects associated with
supraphysiological doses of growth factors. However, several issues remain before
effective bone formation using culture-expanded osteoprogenitors becomes a clinical
reality. These include optimizing cell delivery to a site of bone injury.
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A number of methodologies have been proposed to optimize cell seeding efficiency173–176
and in vitro culture conditions.176–178 However there is limited in vivo evidence179
describing which approaches are most effective at healing a bony defect. Presently in the
clinic, whole bone marrow aspirate can be added to a scaffold material at the time of
implantation. While this approach avoids any in vitro manipulation, and the associated
time and cost, the progenitor number is very low in the bone marrow 37. Previously,
progenitor number has been correlated to the volume of mineralized callus formed after
implantation to a fracture nonunion, and in some cases low progenitor number led to
suboptimal healing.153 By contrast, in vitro expansion can provide large numbers of
osteoprogenitors and therefore increase the therapeutic power of a cell-based approach.
Culture expansion is used here to ensure that large numbers of osteoprogenitors are
delivered to the bony injury. Nonetheless, the degree of cell attachment, distribution, and
phenotype in a cell-seeded scaffold is largely unknown. Therefore the construct initial
conditions (cell attachment, number, viability, phenotype) require continued examination
in terms of in vivo outcomes. Examination of a tissue-engineered construct prior to
implantation can be a useful quality control checkpoint when used in the clinic.86
Previous work in the mouse has shown an upper limit on the length of time
osteoprogenitors can be cultured in vitro and still produce bone in vivo.179 In this case, a
length of about six to eight days corresponded to maximal bone formation, due to
increasing osteoblastic differentiation beyond this period. Similarly, it has also been
suggested that when human cells are used for bone tissue engineering, an osteoprogenitor
phenotype, rather than differentiated osteoblasts, may lead to better in vivo

101

osteogenesis.180

Cell attachment is linked to cell viability through integrin binding181 and may enhance the
survival of implanted cells.88 We sought to evaluate the effect of a cell-attachment period
prior to implantation on bone formation. To examine this question, bone formation within
scaffolds seeded at the time of implantation was compared to scaffolds seeded and
incubated overnight to allow complete cell attachment prior to implantation (Fig. 5-1).
Implanted constructs were examined with radiography and histology after three weeks in
vivo. If cell attachment prior to implantation improves in vivo outcomes, this would have
implications for the clinical delivery of cells, which are currently seeded to a scaffold at
the time of implantation. The vast majority of cells are not attached to the scaffold within
minutes of seeding.182 More critically, it is unclear if the in vivo wound
microenvironment promotes or hinders cell attachment.

We also sought to evaluate the effect of an extracellular matrix (ECM) carrier material on
bone formation, possibly helping to hold cells in position after seeding, and/or conferring
benefits such as synergistic signaling by the ECM.29 The ECM performs several critical
roles in signal presentation and transduction.19,29,183–185 Recent reports have indicated that
the ECM promotes cell retention, survival, and differentiation.88,97,186 Here we evaluated
the use of a reduced growth factor formulation of basement membrane extract (BME) gel
(Cultrex®, Trevigen Inc., also sold as Matrigel®) as a cell suspension to seed
osteoprogenitor cells to a scaffold. BME gel consists mainly of laminin, entactin, and
collagen IV. Four hundred and eighty unique proteins were identified within growth
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factor-reduced BME, representing a complex matrix of extracellular, binding, catalytic,
and regulatory proteins.187

The goals of this work were to (i) examine the effect of a cell attachment period prior to
implantation on bone formation, and (ii) to assess the effect of a complex ECM as a
secondary delivery carrier on bone formation. We evaluated these conditions in two
different collagen-hydroxyapatite scaffolds, Healos® (DePuy) and an in-house scaffold,
here denoted Col-HA. Identifying the optimal conditions for cell-delivery should improve
the efficacy and repeatability of cell-based bone tissue engineering.

5.2

Materials & Methods

5.2.1

Scaffold fabrication and sterilization

To fabricate the in-house scaffold, type-I collagen was first derived from rat tail tendons
following Rajan et al.154 A collagen-hydroxyapatite composite was then formed by selfassembly of collagen fibers in the presence of precipitating hydroxyapatite from a
modified simulated body fluid (m-SBF)188. Briefly, the collagen solution was adjusted to
2.5 mg/mL by a two-fold dilution in sterile ultrapure water at 4 °C. To make a 200 mL
solution of collagen-containing m-SBF, the following salts were added in the order they
appear to the 2.5 mg/mL collagen solution: 1.080 g NaCl, 0.142 g K2PO4, 0.062 g MgCl2,
2.400 g (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) HEPES, 0.175 g CaCl2,
and 0.294 g NaHCO3. While kept cold to prevent collagen fibrillogenesis, the pH of the
solution was adjusted to 7.0 with sodium hydroxide solution and then transferred to a
water bath at 40 °C for 24 hours to allow simultaneous precipitation of hydroxyapatite
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and collagen fibrillogenesis. The gel-precipitate was centrifuged at 11,000 g and 4 °C for
12 min. The supernatant was discarded and the pellet was lyophilized (FreeZone 12L,
Labconco). The collagen-HA precipitate was reconstituted with water at a concentration
of 100 mg/mL, briefly homogenized to obtain a uniform slurry, and frozen in a
polystyrene culture dish from room temperature to -40 °C at a cooling rate of 0.37 °C/min. Following drying, the scaffold was immersed in a solution of 20 mg/mL
EDC [1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride] for 24 hours at
4 °C to covalently crosslink the collagen fibers. The scaffold was then rinsed in a solution
of 5% (w/w) glycine in sterile water for an overnight period in order to block unreacted
EDC. Crosslinking was followed by three sequential rinses in sterile water for 15 minutes
each at 4 °C. Finally, rinsed scaffolds were freeze-dried, cut to a thickness of ~500 µm
with a milling machine and punched to a diameter of 3.5 mm. Scaffolds were terminally
sterilized with a 24-hour cycle of ethylene oxide gas (Anprolene AN74i, Anderson
Products). The Healos® material was received sterile. Healos® is a lyophilized bovine
type-I-collagen sponge with high porosity and a pore size ranging from 4-200 µm, coated
with a thin layer of calcium phosphate.

5.2.2

In vitro culture of bone marrow osteoprogenitors

Mouse BMSCs were isolated from the femur and tibia of OsterixCRE/Ai9 B6 animals.
Osterix is a critical regulator of osteoblast differentiation.189 The combination of the
OsterixCRE and Ai9190 transgenes activate the expression of the TdTomato (red)
fluorescent protein following Osterix expression. This reporter construct activates the
production of TdTomato when a cell expresses Osterix, and continues expression of
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TdTomato in subsequent daughter cells. Thus, following three weeks of in vivo
implantation, the TdTomato signal will label osteoprogenitors, committed osteoblasts,
and osteocytes. Bone marrow cells from femur and tibia were collected by a
centrifugation method. Briefly, interlocking filtration column and collection tubes were
modified by removing the filter and autoclaved. Femur and tibia were cut in half and
placed cut end down in the top tube. The bones were spun at 3100 g for 2 minutes,
ejecting the bone marrow cells into the lower collection tube containing 100 mL of PFE
(98% PBS, 2% FBS, 2 mM EDTA) to prevent clotting. Bone marrow cells were flushed
through a 70 mm cell strainer (BD Biosciences) and re-suspended in α-MEM. Cells were
then added to 100 mm culture dishes in warm α-MEM (Gibco) containing 10% fetal
bovine serum and 1% penicillin-streptomycin. To allow hematopoietic cells to contribute
to the expansion of osteoprogenitor cells, the culture medium was changed four days after
seeding the bone marrow pellet. Two different types of scaffolds (Healos® and Col-HA)
were seeded the day before implantation or incubated overnight, with or without BME
gel as a seeding suspension, resulting in eight groups (n=3). The sample hierarchy is
shown schematically in Fig. 5-1A. Cells were either seeded in a suspension of growth
factor reduced Basement Membrane Extract (BME, 15 mg/mL in PBS, Trevigen) or in a
suspension of α-MEM. The cell suspension was made by adding 15 mL of culture
medium, or cold BME, to a cell pellet containing 1.0×106 cells, resulting in a
concentration of 6.66×107 cells/mL. Prior to seeding, adherent BMSCs were trypsinized
and seeded dropwise on top of either the dry Col-HA scaffold or Healos®. After seeding,
cells were allowed to settle for 30 minutes before an additional one mL of warm culture
medium was added to the culture well. On the day of implantation, samples denoted
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‘implanted immediately’ were seeded with 1.0×106 cells in 15 µL of culture medium, or
BME, and implanted in less than one minute after seeding.

Figure 5-1 | Experimental design and scaffold morphology. (A) Schematic of
Experimental Design. Osteoprogenitors from the bone marrow were expanded in vitro
before seeding to collagen-hydroxyapatite scaffolds and implanted in critical size
calvarial defects. To label areas of active mineralization, calcein was injected
intraperitoneally one-day prior to euthanization at three weeks post-implantation. (B)
Electron micrograph of the Col-HA scaffold showing cellular morphology. Scale bar is
500 µm. (C) Enlarged inset from (A). Scale bar is 100 µm. (D) Electron micrograph of
Healos® scaffold. Scale bar is 500 µm. (E) Enlarged inset from (D). Scale bar is 100 µm.

106

5.2.3

In vivo mouse model of bone repair

On the day of implantation, nod scid gamma immunodeficient mice were anesthetized
with a ketamine (135 mg/kg) – xylazine (15 mg/kg) blend and two 3.5 mm diameter
critical-size defects were made in the right and left parietal lobe using a bur trephine
(RAL #229-030, Benco Dental). Extreme care was taken to prevent damage to the dura
mater beneath the calvarium. Seeded constructs were placed in the defects, alternating the
order of scaffold type in the left and right hole, for each of the 12 animals. Following
closure of the scalp with resorbable sutures, animals were given postoperative analgesic
(bupronephrine, 0.08 mg/kg). One day prior to euthanization at three weeks postimplantation, host mice were injected intraperitoneally with calcein to mark surfaces of
active mineralization. All procedures used in this study were approved by the UConn
Health Center Institutional Animal Care and Use Committee (IACUC).

5.2.4

Image acquisition and analysis

After three weeks of implantation, animals were euthanized, and the extracted calvarium
were fixed in 10% formalin overnight. The following day, samples were placed in a 30%
sucrose solution, while kept cold and in the dark for another overnight period.
Radiographs of calvarium were acquired with a digital X-ray system (MX20, Faxitron).
The samples were then prepared for histology by trimming the calvaria to the defect
regions, and embedding each sample in Cryomatrix (Thermo). Three sections were cut
from each calvarium using a cryostat (Leica) and tape to transfer sections to a glass slide
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(Cryofilm Type2C, Section-Lab). All sections were imaged with a 10× objective on a
fluorescent microscope (Axio Scan.Z1, Zeiss) equipped with stage automation and an
LED light source (Colibri.2, Zeiss).

Bone formation was quantified from radiographic images by selecting a region of interest
(ROI) surrounding only the defect area and calculating the mean pixel intensity using
FIJI.142 To quantify the area fraction of donor cells, calcein label, and darkfield signal
from histological sections for each group, an ROI outlining the defect area was manually
drawn for each image and saved using FIJI. A threshold was then applied to each channel,
and the area fraction was calculated from the total defect area. To process the images as a
batch and ensure the same threshold was consistently applied, a macro was written for
FIJI.

To determine the position of each cell pixel relative to the outside edge of the implant, a
distance mapping technique106 was performed. Briefly, a distance transformation was
applied to the defect region, coding pixel intensity according to pixel distance from the
outer perimeter of the defect (i.e. intensity of 20 corresponds to 20 pixels from the
perimeter). Then a threshold was applied to the cell image and converted to binary (0 for
background, 255 for cells) to be used as a mask when applied to the distance map. The
image calculator tool was used to find the minimum value between the distance map and
the cell mask. Since the cell pixels are always higher than the map pixels in this case, the
resultant image contains distance-coded information at each cell pixel. Noting the spatial
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conversion from pixels to microns, a histogram of the resultant image yields the number
of cell pixels as a function of distance from the outside edge for each section.

5.2.5

Statistical Analysis

Quantitative data is presented as the mean ± standard deviation (error bars and blue bars).
In some cases 95% confidence intervals (light red bars) are also included. A two-sample
independent t-test was used to determine significance between groups. P-values less than
0.05 (both tails) were considered statistically significant and are indicated with an
asterisk. P values less than 0.01, 0.001, and 0.0001 were indicated with two, three, and
four asterisks, respectively.

5.2.6

Permeability Measurement

The permeability, k (m4/Ns), of Healos® and Col-HA scaffolds was measured with water
and a custom flow cell using the following equation found in reference 159:
𝑘=

∆𝑥
2𝜋 ! 𝑟 !
∙
𝐴 ∙ 𝑀!! (𝑀!! 𝑀!! )! − 1

where, ∆𝑥 = scaffold length (m), A = scaffold cross-sectional area (m2), MB1 = mass flow
rate without scaffold (g/s), MB2 = mass flow rate with scaffold (g/s), and r = radius of the
outlet (m).
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5.3 Results
5.3.1

In vitro examination of expanded cells

Four days after plating whole bone marrow, colonies of fibroblastic cells had begun to
appear in the culture dish. Following six days in vitro, colonies had proliferated and
become confluent. When examined using a fluorescent microscope, fibroblastic cells
were positive for the TdTomato osteoprogenitor marker (Fig. 5-2), indicating that large
numbers of osteoprogenitor cells were present in the culture dishes prior to scaffold
seeding.

Figure 5-2 | Osteoprogenitor cells following six days of in vitro expansion. (A) Phase
contrast showing near confluent cell culture, (B) TdTomato reporter driven by
OsterixCRE and (C) Merged image of (A) and (B) indicating a large fraction of cultured
cells are osteoprogenitors.

5.3.2

Radiographic evaluation of calvarial defects following three weeks in vivo

Three weeks after implantation, calvaria were harvested to examine the implants. By
radiographic discrimination (Fig. 5-3), it appeared that all samples contained areas of
radiopacity indicative of mineralized tissue. Both scaffolds contain hydroxyapatite (~30%
by weight), however if collagen-HA scaffolds seeded with cells undergo mineralization
in vivo, a clear increase in radiopacity is observed (an example radiographic progression
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is shown in Fig. 5-4). Two of the 24 scaffolds had moved from the defect region (Fig. 53C and 5-3M), however the remaining implants appeared in good contact with the
surrounding host bone. Quantification of the radiographic images showed significantly
greater radiopacity in the Col-HA samples seeded immediately compared with the ColHA samples provided an overnight incubation (Fig. 5-3N). When BME gel was used as
the seeding medium during overnight incubation of Col-HA samples, the mean
radiopacity was greater than Col-HA samples incubated overnight without BME gel (Fig.
5-3N). Histological examination was performed to further examine implant osteogenesis.
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Figure 5-3 | Radiographs of cell-scaffold constructs after 3 weeks in vivo. (A)-(M) H
and C denote Healos and Col-HA scaffolds, respectively. Scale bars are 1 mm. (N)
Quantitation of radiographs. Light red bars indicate 95% confidence intervals and blue
bars indicate one standard deviation.
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Figure 5-4 | Radiographic progression of calvarial repairs. 4 mm critical-size calvarial
defects filled with Healos® scaffold and neonatal calvarial cells. Radiographs show
progression of increase in radiopacity as scaffolds are mineralized over 7, 14, 21, 28, 60,
and 100 days after surgery. The rightmost image shows the negative control calvarium,
which includes defects filled with the Healos® scaffold alone (right hole) and no scaffold
or donor cells (left hole).

5.3.3

Histological evaluation of calvarial defects following three weeks in vivo

To verify bone formation and determine the distribution of donor cells in the implants
(marked by a TdTomato fluorescent reporter, Fig. 5-2), histological sections of the
calvaria were generated (Fig. 5-5). Histological examination of the implants showed bone
formation in several samples, indicated by donor cells embedded in a mineral phase (Fig.
5-5, right column, blue arrows). Modest bone formation was found in the Col-HA groups
incubated overnight (Fig. 5-5A and 5-5E). The Healos® samples appeared to contain
more bone and less scaffold than the Col-HA samples, which contained areas of scaffold
still intact (Fig. 5-5F and 5-5N, white astericks). Several pores in the Col-HA scaffolds
did not contain donor cells (Fig. 5-5A, 5-5F, and 5-5N), suggesting limited cellular
invasion.

The Healos® samples without incubation (Fig. 5-5K and 5-5O) had larger marrow spaces
than the Healos® samples with an overnight incubation prior to implantation (Fig. 5-5C
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and 5-5G). Marrow spaces also contained cells of donor origin (Fig. 5-5P and 5-5L).
Fewer marrow niches appeared to have emerged in the Col-HA samples (Fig. 5-5A, 5-5E,
and 5-5M).

Donor cells were found on the surface of the mineral label, pointing to their contribution
to bone formation in the defects (Fig. 5-5, white arrows). Mineral label was present in all
samples, indicating the label was able to diffuse into the tissue by systemic delivery.
Some regions of the Col-HA scaffold appeared to take up the mineral label as a weak
nonspecific stain (Fig. 5-5F and 5-5N, white astericks) rather than a distinct line
characteristic of an active mineralizing surface.
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Figure 5-5 | Histological sections of defects following 3 weeks of in vivo implantation.
(Left column) Defect wide view of scaffolds and mineralized tissue (darkfield channel),
+TdTomato donor cells (red), and the mineralization label (green, calcein). Scale bars are
500 µm. (Right column) Magnifications of left column. Blue arrows indicate +TdTomato
donor cells embedded in bone. White arrows indicate +TdTomato donor cells overlying
mineral label. Scale bars are 100 µm.
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5.3.4

Quantitative histomorphometry following three weeks in vivo

To quantitatively compare the experimental groups, a histomorphometric analysis was
performed. Analysis of the darkfield channel (shown as the grayscale channel in Fig. 5-5)
indicated that the Col-HA groups implanted immediately had a higher mean darkfield
area fraction than the Col-HA groups incubated overnight (Fig. 5-6A). It should be noted
that the darkfield signal contains areas of bone and scaffold, as shown in Fig. 5-5E. When
the donor cell area fractions were examined, both Healos® and Col-HA samples wherein
cells were implanted immediately had significantly higher area fractions of donor cells
than the same scaffold type given an overnight attachment period (Fig. 5-6B). The ColHA samples implanted immediately had a higher mean calcein area fraction compared
with the Col-HA samples incubated overnight (Fig. 5-6C). By contrast, the mean donor
cell and calcein area fractions were very similar whether or not BME gel was applied. As
a whole, histomorphometric analysis of the darkfield, donor cell, and calcein area
fractions supported the notion that immediate implantation led to an defect with more
donor cells and mineralizing surfaces compared with samples incubated overnight.
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Figure 5-6 | Quantitative histomorphometry of darkfield, donor cell, and calcein
channels. (A) Quantification of the darkfield area fraction in the defect area. (B)
Quantification of donor cell area fraction using TdTomato signal. (C) Quantification of
mineralizing surface using the calcein mineralization label. Light red bars indicate 95%
confidence intervals and blue bars indicate one standard deviation.
To examine the effect of scaffold type and delivery method on the distribution of donor
cells in the implant, a distance analysis was performed. For each defect, a distribution of
donor cells as a function of distance from the outside edge of the implant was generated.
When viewed by scaffold type, the donor cell distribution in the Healos® samples was not
significantly deeper when compared to the Col-HA samples (Fig. 5-7A). Interestingly,
the groups incubated overnight had significantly deeper mean cell penetration when BME
gel was included, regardless of scaffold type (Fig. 5-7B). The inclusion of BME gel may
increase cell penetration only if cells are incubated in the scaffold overnight.
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Figure 5-7 | Donor cell distribution in the scaffolds. (A) Comparison of donor cell
distribution from the outside edge of the implant for Healos® and Col-HA. Error bars
indicate one standard deviation. Plot above shows a comparison of the means for each
sample according to scaffold type. (B) Comparison of the mean donor cell distance from
the outside edge of the implant. Light red bars indicate 95% confidence intervals and blue
bars indicate one standard deviation.

5.3.5

Permeability measurement of scaffolds used in vivo

When the permeability of the two scaffolds was compared, the Healos® sample was more
permeable than the Col-HA sample by three orders of magnitude, 4.2 ± 3.4×10-9 and 2.9
± 3.0×10-12 m4/N-s, for Healos® and Col-HA, respectively.

5.4 Discussion
We examined if an in vitro cell attachment period before implantation, and/or an ECMbased delivery suspension, would improve donor cell survival and bone formation in vivo.
The outcome of the experiment presented here suggests that immediate implantation
improves donor cell delivery and scaffold mineralization; likely due to a higher number
of cells implanted in this case (Fig. 5-8). Immediate loading corresponded to a higher
mean radiopacity in the Col-HA scaffolds compared with Col-HA scaffolds provided
with an overnight incubation (Fig. 5-3N). Similarly, the donor cell area fraction was
significantly higher for both types of scaffolds implanted immediately compared with the
same scaffold type incubated overnight. Finally, the mean area fraction of the
mineralization label was significantly higher for the Col-HA scaffolds implanted
immediately compared with Col-HA scaffolds given an overnight incubation (Fig. 5-6C).
This suggests that cell attachment and survival may not be hampered by the in vivo
microenvironment of a fresh bone injury. Furthermore, immediate seeding and
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implantation is faster, requires less cell manipulation, and in this study, enabled the
delivery of significantly higher numbers of donor cells (Fig. 5-8). The efficient use of a
precious cell source would also be advantageous to the user. An increase in radiopacity
was not found in the Healos® groups seeded immediately, possibly because of bone
remodeling characteristic of a more advanced healing stage 55. This was evidenced by the
large marrow spaces found in Fig. 5-5K and 5-5O, which would reduce the overall
radiopacity compared to Healos® groups incubated overnight (Fig. 5-5C and 5-5G).

Figure 5-8 | Comparison of cell number in Col-HA scaffolds. Cell number was
evaluated immediately after loading and following an overnight incubation with and
without BME gel. Light red bars indicate 95% confidence intervals and blue bars indicate
one standard deviation.
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Tissue engineers should endeavor to form bone with the marrow spaces found
anatomically. For instance, the large marrow spaces of the long bone diaphysis would be
inappropriate in the calvarium, which contains smaller marrow spaces. Larger marrow
spaces were observed between the Healos® groups implanted immediately (Fig 5-5K and
5-5O), compared with the Healos® groups provided an overnight incubation (Fig. 5-5C
and 5-5G). The same trend was found when comparing the darkfield area fractions in Fig.
5-6A. Lower darkfield area fractions corresponded to Healos® samples with larger
marrow spaces shown in Fig. 5-5K and 5-5O, although this effect was not significant here,
possibly due to low statistical power (n=3). Increased remodeling in samples implanted
immediately may stem from a greater hematopoietic fraction, the population responsible
for producing bone-remodeling osteoclasts. In other words, an overnight incubation could
select for a more homogeneous population of mesencyhmal stem cells. Adherence to
tissue culture plastic is a well-known selector of mesencyhmal stem cells from the bone
marrow,191,192 and a second attachment process may purify this population by further
removing non-adherent hematopoietic cells. As an indicator of bone resorption, we
examined a marker for osteoclast activity using TRAP staining of histological sections
from the implants (Fig. 5-9). We did not find differences in TRAP activity corresponding
to delivery with or without an overnight incubation period. However it is possible that
differences in osteoclast activity were present at an earlier time point and would not be
observed by examining osteoclast activity after such a remodeling event.
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Figure 5-9 | TRAP and H&E staining of histological sections. (Left column) TRAP
staining (yellow) superimposed on darkfield images of transverse scaffold sections.
(Right column) Hematoxylin and eosin staining of histological sections. Scale bars are
500 µm.
An in vitro test showed significantly higher loading numbers in Col-HA scaffolds
simulating the immediate implantation method compared with overnight incubation (Fig.
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5-8). The discrepancy in cell number between immediate implantation versus overnight
incubation samples was due to cell loss to the culture dish when medium was added to
the scaffold and when the scaffold was removed from the dish, therefore we expect
similar results for Healos® scaffolds. It is tempting to speculate that the delivery of a
greater number of MSCs in the samples delivered immediately could lead to a more
potent hematopoietic niche, resulting in larger marrow spaces in the Healos® groups
implanted immediately. The evidence supporting this hypothesis stems from the finding
that implanted MSCs create a hematopoietic microenvironment that leads to the
establishment of marrow cavities.191 Krebsbach et al. noticed that the delivery of higher
numbers of MSCs in a thick gelatin vehicle corresponded to the establishment of larger
marrow spaces, even though the hematopoietic fraction was very small.164 Similarly, Liu
et al., using cell sorting to generate a homogeneous population of osteoprogenitors,
observed larger marrow spaces with a higher cell loading.42 MSC number positively
correlates with bone formation in sites of bone injury.153 However, MSCs are also a
critical component of the native hematopoietic microenvironment and strongly regulate
hematopoietic stem cell function through cell-secreted factors (e.g. CXCL12) and cell
adhesion proteins (e.g. Nestin).50,193 Further work is needed to examine if the number of
seeded MSCs affects the marrow size of a bony implant.

We also investigated if delivering cells to the scaffolds in a complex ECM would
enhance in vivo bone formation. Several groups have observed beneficial effects of ECM
proteins on wound repair and bone formation.29,88,97,186 ECM proteins can sequester and
synergistically amplify signaling factors.29,185 Furthermore, a two-component system of
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collagen-hydroxyapatite is far simpler than the composition of bone.6 Herein, cells were
delivered to scaffolds in a suspension of liquid BME that later gelled upon incubation at
37 °C. The application of BME gel improved cell penetration (Fig. 5-7) in both scaffold
types and increased the mean radiopacity of the Col-HA scaffolds (Fig. 5-3N), only when
an overnight incubation period was applied. This could be due to BME gel acting to hold
cells in place in vitro, since without BME gel, cells can be removed during medium
addition after initial seeding and scaffold removal from the culture dish. The evidence to
support this hypothesis is that cells depend on proteolytic degradation of the surrounding
matrix in order to migrate through BME194. This would slow cell migration in BME gel
compared with an environment where cells do not require matrix degradation to migrate.
Similarly, gels typically have a relatively low permeability, (Collagen gel, k~10-13-10-12
m4/Ns)195, which could also reduce cell migration. This suggests that improved cell
distribution in scaffolds incubated overnight with BME gel may not be due to enhanced
migration, but rather improved cell retention in the scaffolds in vitro. The reason that this
effect was not observed in the samples implanted immediately could be due to the higher
number of delivered cells in groups implanted immediately (Fig. 5-8). Alternatively, if
the effect of BME application on the cell distribution were small for the immediately
seeded groups, this would not be noticed here given the small number of animals per
group (n=3).

Some of the Col-HA samples contained modest bone formation (Fig. 5-5E and 5-5A)
compared with the Healos samples (Fig. 5-5C and 5-5G), even when both scaffolds were
incubated overnight. The Healos scaffolds had a permeability three orders of magnitude
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higher than the Col-HA samples used in this study. It has been previously shown by
Mitsak et al., using polycaprolactone scaffolds and a 3-D printing approach, that
increased scaffold permeability led to more bone ingrowth in vivo.196 Future work should
evaluate the effect of collagen-HA scaffold permeability on bone formation in vivo.

5.5 Conclusion
In summary, we evaluated the effect of an in vitro attachment period, the use of BME gel
as a cell delivery vehicle, and scaffold type on bone formation in vivo with cultureexpanded mouse BMSCs. Both scaffold types, with or without an overnight attachment
period, were osteogenic in vivo following three weeks of implantation. Quantitation of
the radiographic images revealed that Col-HA scaffolds implanted immediately had a
higher mean radiopacity than Col-HA scaffolds incubated overnight. Similarly, Col-HA
scaffolds implanted immediately had higher mean area fractions of donor cells and
mineralizing surfaces compared with Col-HA scaffolds incubated overnight. Healos
groups implanted immediately had higher area fractions of donor cells compared with
Healos scaffolds incubated overnight. The addition of BME gel did not exert a strong
effect on the metrics examined here when cells were implanted immediately. However,
the use of BME gel as a cell suspension, improved the donor cell distribution in the
scaffold when an overnight incubation period was applied. When an in vitro test of cell
delivery was performed using the Col-HA scaffolds, a higher cell loading was found for
the immediate implantation method compared with overnight incubation, with or without
BME gel. Due to potential cell loss during overnight incubation, immediate implantation
following cell seeding may be a preferable method. These results should be useful when
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deciding how to deliver cells to a bony defect for optimal cell-based bone tissue
engineering.

127

6 Improving the permeability of lyophilized collagenhydroxyapatite scaffolds for cell-based bone
regeneration with a gelatin porogen

6.1 Introduction
Cell-based bone tissue engineering has shown encouraging results in animal
models64,65,164,172,197,198 and even in a few human patients62,63. This method could
supplement or replace autologous bone as a bone grafting material, since progenitor cell
harvesting would inflict far less damage to existing bone. However the factors that lead to
successful healing of bony defects using cells are still poorly understood, and this
approach has lagged behind growth factor based approaches.66 Currently, high doses of
growth factors are required for bone formation and negative side effects have been
observed in some patients.77,199,200 A cell-based approach (or combination of cells and
factors) could theoretically sidestep issues of negative side effects and harness the ability
of cells to secrete hundreds of different factors in concert with the healing cascade, yet
challenges remain. One such challenge is the design of a biomaterial scaffold to deliver
cells and support osteogenesis in vivo. So far, an ideal scaffold for bone tissue
engineering has not been identified,68 and specific scaffold designs may be required for
healing bony defects depending on anatomical location, among other factors.
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Collagen-calcium phosphate composite scaffolds are a class of bone-forming
biomaterials that are easily remodeled by cell-secreted MMPs, contain ions for
mineralization, and have already shown promise in the clinic with bone marrow
extract.201,202 While bone marrow contains an osteoprogenitor population, these cells are
quite rare in the bone marrow population (0.001 to 0.01%).37 Bone marrow
osteoprogenitors can be greatly expanded in culture, improving the therapeutic potency
when higher numbers of osteoprogenitors are seeded to a site of bone injury.153 We have
developed a collagen-hydroxyapatite (HA) scaffold that is osteogenic in preclinical in
vivo models of cell-based bone repair with culture-expanded bone marrow
osteoprogenitors.89,92,182 However the cellular morphology of lyophilized collagen-based
scaffolds can sometimes result in a relatively low permeability. We previously observed
that collagen-HA scaffolds with a permeability of 10-12 m4/Ns, despite large pores (>100
µm) and a high porosity (>90%), resulted in modest bone formation in a critical-size
calvarial defect, owing to limited cellular invasion of the scaffolds (manuscript in
preparation). The commercial scaffold used as a control in this experiment (Healos®) had
a permeability of 10-8 m4/Ns and performed better in this in vivo test. Mitsak et al.
demonstrated that polycaprolactone scaffolds produced by a 3D printing method with a
permeability of 10-7 m4/Ns led to greater new bone infiltration in vivo than the same
material with a permeability of 10-8 m4/Ns. We therefore hypothesized that collagen-HA
scaffolds with greater permeability would lead to better bone formation. Furthermore we
investigated the use of a gelatin porogen to further increase the permeability of
lyophilized collagen-HA scaffolds.
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Since the pore structure of lyophilized collagen scaffolds is created by an ice template, it
is difficult to apply a salt leaching technique203 to improve permeability, owing to the fact
that the salt would simply dissolve in the aqueous phase. Furthermore, since collagen
denatures above 50 °C204, in acidic conditions, and in a variety of chemical solvents, a
sacrificial porogen phase would have to be removed under gentle temperature, pH, and
solvent conditions. Han et al. developed a series of elegant porogen methods that fulfill
these requirements, namely gelatin, hyaluronan, and alginate microparticles that can be
removed by incubation at 37 °C, hyaluronidase, and EDTA addition, respectively.205
Inspired by Han et al., we used gelatin microspheres as a nontoxic porogen to increase
the permeability of lyophilized collagen-HA scaffolds, obtaining a 4-fold increase in
permeability. We then sought to evaluate and compare the in vivo performance of
improved permeability of scaffolds to that of the lower permeability found in our prior
experiment (~10-12 m4/Ns) and scaffolds without the gelatin porogen (~10-9 m4/Ns). As
discussed by Dias et al.,206 permeability encapsulates a variety of scaffold architectural
parameters; such as porosity, pore size, and interconnectivity. Furthermore, permeability
is a functional mass transport property that has been correlated to bone formation in
vivo.196 Permeability can be implemented as an important quality control measure in the
production of lyophilized collagen scaffolds. The effects of collagen-HA scaffold
permeability on bone formation have not yet been well defined in the context of in vivo
outcomes. Identifying reliable predictors of bone formation is a critical step towards
consistent and effective cell-based bone regeneration.
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6.2 Materials & Methods
6.2.1

Gelatin microbead fabrication

Gelatin microbeads were fabricated using an oil and water emulsion method.205 First,
type-A gelatin (Fisher) was added to distilled water at a concentration of 10 % (w/v) and
autoclaved. Three mL of gelatin solution was added dropwise to 15 mL of 10% Tween 20
(Acros) in extra virgin olive oil at 40 °C with stirring at 700 rpm. The emulsion was held
at 40 °C and 700 rpm for 10 minutes followed by reducing the stirring rate to 200 rpm
and placing the solution in an ice bath for 30 minutes to gel the microbeads. To remove
the olive oil from the gelatin microbeads, the emulsion was added to a centrifuge tube
along with cold PBS and spun at 700 rpm for 5 min, removing the oil-water supernatant
and repeating five times. Washed gelatin microbeads were kept in sterile PBS at 4 °C
until use.

6.2.2

Scaffold fabrication and sterilization

Type-I collagen was first derived from rat tail tendons following Rajan et al.154 A
collagen-hydroxyapatite composite was formed by simultaneous self-assembly of
collagen fibers in the presence of precipitating hydroxyapatite from a modified simulated
body fluid (m-SBF).188 Briefly, the collagen solution was adjusted to 2.5 mg/mL by a
two-fold dilution in sterile ultrapure water at 4 °C. For a 200 mL solution of m-SBF, the
following salts were added in the order they appear: 1.08 g NaCl, 0.1428 g K2PO4, 0.0622
g MgCl2, 2.4 g HEPES, 0.1758 g CaCl2, and 0.294 g NaHCO3. While kept cold, the pH of
the solution was adjusted to 7.0 with a sodium hydroxide solution and then transferred to
a water bath at 40 °C for 24 hours to allow simultaneous precipitation of hydroxyapatite
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and collagen fibrillogenesis. The gel-precipitate was centrifuged at 11,000 g and 4 °C for
12 min. The supernatant was discarded and the pellet was lyophilized (FreeZone 12L,
Labconco). The collagen-HA precipitate was reconstituted with water at a concentration
of 100 mg/mL and briefly homogenized (Tissuemiser, Fisher) to obtain a uniform slurry.
Gelatin microbeads were added to the slurry at a ratio of 1:5, 1:1, and 1:0 collagenHA:gelatin (w:w). To impart a porous structure, the slurries were frozen from room
temperature to -40 °C at a cooling rate of -0.37 °C/min using a program implemented by
the freeze dryer. Following drying, the scaffolds containing beads were placed in sterile
PBS at 37 °C overnight to remove the gelatin porogen. To covalently crosslink the
collagen fibers, scaffolds were immersed in a solution of 20 mg/mL EDC [1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride] for 24 hours at 4 °C. The scaffold
was then rinsed in a solution of 5% (w/w) glycine in sterile water for an overnight period
in order to block unreacted EDC. Crosslinking was followed by three sequential rinses in
sterile water for 15 minutes each and a final rinse for three days at 4 °C. Finally, rinsed
scaffolds were freeze-dried again, cut to a thickness of ~500 µm and punched into a
diameter of 3.5 mm. Scaffolds were terminally sterilized with a 24-hour cycle of ethylene
oxide gas (Anprolene AN74i, Anderson Products).

6.2.3

Micro computed tomography

Three-dimensional reconstructions of scaffolds were acquired using an Xradia
MicroXCT-400. To enhance the contrast of collagen-HA scaffolds, they were soaked in
1% iodine in ethanol overnight and dried before tomography. 1,500 images were acquired
at an angle of -91˚ to 91˚ with an exposure time of 10 s, a source power of 3 W, a voltage
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of 40 kV, and a 20x objective. Tomography images were reconstructed with XM
Reconstructor (Xradia) and viewed with the 3D viewer plugin for the FIJI distribution of
NIH ImageJ.142 Scaffold porosity, pore thickness, wall thickness, and anisotropy were
calculated from tomography data using the BoneJ plugin for FIJI.156
6.2.4

Permeability Measurement

The permeability, k (m4/Ns), of Healos® and Col-HA scaffolds was measured with water
and a custom flow cell using the following equation found in reference 159:
𝑘=

∆𝑥
2𝜋 ! 𝑟 !
∙
𝐴 ∙ 𝑀!! (𝑀!! 𝑀!! )! − 1

where, ∆𝑥 = scaffold length (m), A = scaffold cross-sectional area (m2), MB1 = mass flow
rate without scaffold (g/s), MB2 = mass flow rate with scaffold (g/s), and r = radius of the
outlet (m).
6.2.5

In vitro culture of bone marrow osteoprogenitors

Mouse bone marrow stromal cells (BMSCs) were isolated from the femur and tibia of
Col3.6cyan CD1 transgenic mice (Fig. 6-1A). The Col3.6cyan reporter construct
activates the production of cyan fluorescent protein when a cell expresses the type I
collagen gene. The 3.6 kb fragment of the COL1A1 promoter region, implemented in the
Col3.6cyan reporter, can be used as a marker for differentiated osteoblasts.207 Bone
marrow from the femur and tibia of Col3.6cyan transgenic mice was collected by a
centrifugation method. First, interlocking filtration column and collection tubes, with the
filters removed, were autoclaved. Femur and tibia were placed in the top tube and cells
were spun at 3100 g for 2 minutes into the second tube containing 100 uL of 98% PBS,
2% FBS, and 2 mM EDTA (PFE) to prevent clotting. Bone marrow cells were flushed
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through a 70 mm cell strainer (BD Biosciences) and re-suspended in α-MEM. Cells were
then added to 100 mm culture dishes in warm α-MEM (Gibco) containing 10% fetal
bovine serum and 1% penicillin-streptomycin. To allow hematopoietic cells to contribute
to the expansion of osteoprogenitor cells, the culture medium was changed 4 days after
seeding. On the day of implantation, adherent BMSCs were trypsinized and seeded
dropwise onto the top the dry collagen-HA scaffold at a density of 1.0×106 cells in 15 µL
of culture medium. Six cell-seeded scaffolds were implanted for each of three groups,
Group N – collagen-HA no beads, Group 1:1 - 1:1 ColHA:Beads, and Group 1:5 – 1:5
ColHA:Beads (Fig. 6-1A).
6.2.6

In vivo critical-size mouse calvarial defect model

On the day of implantation, NOD scid gamma (NSG) immunodeficient host mice were
anesthetized with a ketamine (135 mg/kg) – xylazine (15 mg/kg) blend. Two 3.5 mm
diameter critical-size calvarial defects were made in the right and left parietal lobe using
a bur trephine (RAL #229-030, Benco Dental). Extreme care was taken to prevent
damage to the dura mater beneath the calvarium. Cell-seeded scaffolds were placed in
each of the two defects per animal. Following closure of the scalp with resorbable sutures,
animals were given postoperative analgesic (bupronephrine, 0.08 mg/kg). One day prior
to euthanization at three weeks post-implantation, host NSG mice were injected
intraperitoneally with calcein to mark surfaces of active mineralization. All procedures
used in this study were approved by the UConn Health Center Institutional Animal Care
and Use Committee (IACUC).
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6.2.7

X-Ray, Histology and histomorphometry

After three weeks of implantation, animals were euthanized using CO2 asphyxiation, and
the extracted calvarium were fixed in 10% formalin overnight, followed by 30% sucrose
solution overnight, while kept cold and in the dark. Radiographs of calvarium were
acquired with a digital X-ray system (MX20, Faxitron). The samples were then prepared
for histology by trimming the calvaria to the defect regions and embedding each sample
in Cryomatrix (Thermo). Six sections were cut from each calvarium using a cryostat
(Leica) and tape (Cryofilm Type2C, Section-Lab) to transfer sections to glass slides. All
sections were imaged with a 10x objective on a fluorescent microscope (Axio Scan.Z1,
Zeiss) equipped with stage automation for high throughput imaging (Zen software, Zeiss).

Bone formation was quantified from radiographic images by selecting a region of interest
(ROI) surrounding the implant area, but excluding regions overlapping with host bone,
and calculating the mean pixel intensity using FIJI.142 To quantify the area fraction of
donor cells, calcein label, nuclei, and DIC signal from histological sections, an ROI
outlining the defect area was manually drawn for each image and saved using FIJI. A
threshold was then applied to each channel, and the area fraction of the total defect area
was calculated. To process the images as a batch and ensure the same threshold was
consistently applied, a macro was written for FIJI that sequentially processed images
using their corresponding ROIs. Nuclei embedded in bone were classified as such if they
were found within the DIC signal. This was calculated using the ‘AND’ image processing
calculation between the nuclei and DIC channels. Areas where donor cells and
mineralization label were in close proximity (indicative of active donor mineralization)
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were found by an 8× dilation of each channel followed by the ‘AND’ operation to find
areas of overlap.
6.2.8

Statistical analysis

A two-sample independent t-test was used to determine significance between groups. Pvalues less than 0.05 (both tails) were considered statistically significant and are
indicated with an asterisk. P values less than 0.01, 0.001, and 0.0001 were indicated with
two, three, and four asterisks, respectively. The complete histomorphometry dataset was
organized by a hierarchical clustering algorithm (complete linkage method with
Euclidean distance measure) and plotted using the R statistical programming package.208

6.3 Results
6.3.1 Scaffold architecture
To examine the influence of scaffold permeability on bone formation, we fabricated three
types of scaffolds; two containing a 1:1 and 1:5 ratio (w:w) of collagen-HA precipitate to
gelatin bead porogen (Fig. 6-1E and 6-1F, respectively), and another scaffold without a
bead porogen (herein termed N for normal, Fig. 6-1D). The gelatin bead porogen had an
average diameter of 25.10±15.97 µm (Fig. 6-1C). Removing the porogen led to samples
with an average permeability 4-fold higher than the samples without porogen (Fig. 6-1B
and Table 3). Increasing the bead content 5-fold did not further increase the scaffold
permeability. Cross-sections of each scaffold type are shown in Fig. 6-1. All the scaffolds
had a cellular architecture (Fig. 6-1) when viewed in cross-section. It can be difficult to
appreciate the morphology of the collagen-HA scaffolds by SEM alone since the cutting
procedure can flatten the structure (Fig. 6-1E). To non-invasively examine the scaffold
morphology in three dimensions, we performed x-ray microtomography.
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Three-dimensional reconstructions of the scaffolds (Fig. 6-2A through 6-2C) were
analyzed to examine the pore morphology of the void space. A sphere-filling algorithm
was used to describe the void space according to the size of sphere that fit within its
bounds. A higher grayscale value (more white) indicates a larger sphere diameter (Fig. 62D through 6-2E). A slight increase in porosity and mean pore size was observed for
samples in which the bead porogen was applied (Fig. 6-2G and Table 3). The fraction of
pores greater than 90 µm increased in both bead porogen samples (Fig. 6-2G). The
scaffold wall thickness remains essentially the same, approximately 5 µm. When
comparing the values of structural anisotropy, all scaffolds are randomly organized, with
slightly more anisotropy in the bead-loaded samples. Taken together, the bead porogen
appeared to increase the fraction of larger pores and the randomness of the scaffold
architecture.
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Figure 6-1 | Experimental design and enhanced scaffold permeability using a gelatin
porogen. (A) Schematic of the in vivo experiment. (B) Measurement of scaffold
permeability for each of the in vivo groups, log scale. (C) Particle size distribution of the
gelatin microbead porogen used. (inset) Micrograph of the gelatin microbeads. Electron
micrographs of scaffolds fabricated without the gelatin bead porogen, group N (D), and
with the porogen, group 1:1 (E) and 1:5, (F). Scale bars in (D)-(F) are 100 µm.

Figure 6-2| Three-dimensional reconstructions of scaffolds and pore volumes coded
according to pore size. 3D reconstructions from tomography data for the (A) N, (B) 1:1,
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and (C) 1:5 scaffolds. All scale bars 100 µm. Color-coded pore volumes of (D) N, (E) 1:1,
and (F) 1:5 scaffolds after a sphere-filling algorithm. Pore volumes are shown from the
approximately the same perspective as the scaffold volumes above. (G) Pore thickness
distributions from the tomography data. Red bar in (G) shows the mean pore thickness.
Sample

Porosity

N
1:1
1:5

91.81
95.25
93.59

Mean Pore
Thickness (µm)
58±32
79±60
91±59

Mean Wall
thickness (µm)
5.91±3.3
5.16±2.3
4.89±2.1

Mean Permeability
(m4/Ns)
2.17±1.63×10-9
9.16±2.01×10-9
8.8±1.59×10-9

Scaffold
Anisotropy
0.50815
0.39975
0.44242

Table 3 | 3D architectural parameters from tomography data and scaffold
permeability. The value of the anisotropy parameter tends toward zero for randomly
oriented structures and to one for parallel flat plates.

6.3.2

Radiographic examination of implants after three weeks in vivo

Six scaffolds from each of the three scaffold types (N, 1:1, 1:5) were combined with
culture-expanded bone marrow cells and implanted into critical-size calvarial defects of
immunodeficient mice. Two of the animals in this study showed signs of disease and
were excluded from the quantitative analysis herein based on their health (calvaria from
these animals are shown in 6-3F and 6-3I). Three weeks after implantation all mice were
euthanized and their calvaria were harvested for examination, first by stereomicroscopy
and radiography. When viewed on the stereomicroscope, some implants were very
opaque when illuminated from behind, most notably Fig. 6-3A, 6-3E, and 6-3G, insets.
Blood vessels were also visible on the surface of the implants in all cases. Movement of
the scaffolds following implantation was apparent in several samples (Fig. 6-3A, 6-3B, 63C, 6-3E, 6-3F, and 6-3H). When the radiographs were viewed, all samples contained
regions of high relative radiopacity, indicative of mineralized tissue. When the
photomicrographs were quantitatively compared, the 1:1 group had a significantly higher
mean gray value in the defect compared to the N group. To evaluate the status of the
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seeded donor cells, and to confirm scaffold mineralization, the calvarial implants were
sectioned and viewed with brightfield (Fig. 6-5) and fluorescence (Fig. 6-6) microscopy.

Figure 6-3 | Radiographs of implants following three weeks in vivo. (A)-(I) X-ray
micrographs of calvarial defects filled with collagen-HA scaffolds seeded with cultureexpanded BMSCs. Insets are photographs of the defects. All scale bars are 1 mm. (J)
Quantitation of radiopacity in the implant region.

6.3.3

Histological evaluation of implants after three weeks in vivo

Upon examination of histological sections from each group stained with hematoxylin and
eosin, it was apparent that the signal observed from the radiographs was due to
mineralized tissue (deep purple and red asterisks, Fig. 6-5A, 6-5C, and 6-5E). A layer of
matrix and cells was also visible on the top and bottom of the implants, which was in
some cases thickened at the margins of the implant (Fig. 6-5A and 6-5E, black arrows).
Marrow cells were found in the defect interiors, suggesting the establishment or
development of a new marrow niche (Fig. 6-5B and 6-5D, red pound signs). All scaffolds
contained a high cell density and the porogen scaffolds were particularly dense with very
little unfilled space. Blood vessels could also be seen at the bottom of the defect,
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suggesting a vascular contribution from the dura mater (Fig. 6-5F, green arrows). Dense
aggregates of red blood cells are visible in center of the sample pictured in Figs. 6-5C and
6-5D (green triangles), potentially remnants of clots that formed within the scaffold.

To evaluate the persistence and activity of donor cells and the intravenous mineralization
label, fluorescent images were evaluated (Fig. 6-6). From this perspective, it was clear
that donor cells had differentiated into osteoblasts, indicated by expression of the
Col3.6cyan reporter gene, which was not active following six days of culture (Fig. 6-4).

Figure 6-4 | Col3.6cyan osteoblast reporter is not active following six days of
expansion in vitro. Scale bar is 100 µm.

Donor osteoblast cells (cyan) appeared well distributed throughout the thickness of the
scaffolds, as well as the calcein mineralization label given one day prior to euthanization.
Several sites of active donor cell mineralization were apparent, indicated by cyan cells in
close proximity to the green calcein mineralization label (Fig. 6-6B, 6-6D and 6-6F,
yellow arrows). Hoechst staining of cell nuclei (Fig. 6-6, red) showed a high number cells
located throughout the defects. Nuclei were present embedded in the mineral phase in
several locations, suggesting new bone had formed, rather than misinterpreting the
collagen-HA scaffold for new bone. The mineralized implants were integrated to host
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bone in some areas (Fig. 6-6, white arrows). Taken together, the histological sections
show that samples in each group contained new bone, were actively mineralizing further,
and contained a high cell density. Furthermore, donor cells had survived implantation and
had differentiated into bone forming osteoblasts that localized to mineralizing surfaces.

Figure 6-5 | Histological sections of implants stained with hematoxylin and eosin.
Representative images of implants from each group (A)(C)(E) and higher magnifications
(B)(D)(F). Black arrows in (A) and (E) indicate periostieal membrane thickening at
defect margins. Red astericks in (A),(C), and (E) mark bone. Green triangles in (C) and
(D) show red blood cells and bone marrow cells, red pound signs in (B) and (E). Blood
vessels can be seen in (F), green arrows. Scale bars at left are 500 µm and 100 µm at right.
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Figure 6-6 | Fluorescence microscopy of histological sections showing donor cells
and mineralization label. Representative images of histological sections from each
group showing donor osteoblast cells (cyan), calcein mineralization label (green),
hoescht-labelled nuclei (red), and DIC channel (gray). White arrows in (A), (C), and (E)
indicate areas of implant integration with the host bone. Yellow areas in magnified
images at right show donor osteoblast cells overlying the calcein mineralization label.
Scale bars are 500 µm at left and 100 µm at right.

6.3.4

Quantitative histomorphometry of implants after three weeks in vivo

To quantitatively compare the osteogenic potential of each group, a histomorphometric
analysis of tissue sections was performed. Six metrics were evaluated for each of the
replicate serial sections from one of the 18 defects, resulting in a total of 106 images.
Four of the metrics were area fractions within the defect area of each of the four channels
acquired during fluorescence imaging (DIC.AF-bone and scaffold, HOESCHT.AF-cell
nuclei, CALCEIN.AF-mineralization label, and CFP.AF-donor osteoblast cell area
fractions). Two additional metrics were calculated to capture the bone forming activity
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and a measure of the new bone formed. Since it can be difficult to distinguish scaffold
from new bone based on the DIC channel alone, we counted the area fraction of cell
nuclei embedded in the DIC signal, indicative of cells trapped in newly formed bone (Fig.
6-7B). This metric was termed the ‘area fraction of embedded nuclei’ and appears on the
plot in Fig. 6-7A as the HOESCT.DIC area fraction (H.D.AF). To estimate the bone
forming activity by donor cells, we classified and counted regions where donor
osteoblasts were overlying a strong mineralization label (Fig. 6-7E, with and without a
red overlay showing a classified mineralization site). This metric was termed ‘active
mineralization sites’ and appears in the plot in Fig. 6-7A as the CALCEIN.CFP area
fraction (CAL.CFP.AF).

Following image processing, a hierarchical clustering algorithm was applied to the
complete dataset (Fig. 6-7A). Each image (named at right, Fig. 6-7A) was classified
according to its similarity to the other images based on the six metrics calculated (named
at bottom). The clustered dataset showed four groups at the 2nd clade-level that
corresponded with the quality of the repair. The top group (clade α) contained images of
qualitatively good mineralizing defects with high area fractions of the DIC, nuclei and
donor cell signal. Correspondingly, this group had high numbers of embedded nuclei and
active bone mineralization sites. A sample image from this group is shown in Fig 6-8A.
By contrast, at the bottom of this dataset, the clade δ group contained images of
qualitatively poorly mineralized defects with low area fractions of mineralization label,
embedded nuclei and donor cells overlying the mineralization label. A representative
image from the clade δ group is included in Fig. 6-8B. The intermediate groups (clade γ
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and β) contained defects that scored within these bounds. The clustered data suggests that
the combination of metrics used here can distinguish between qualitatively good and bad
bone repairs in this experiment. Viewing the spread of values for the area fractions of
donor cell mineralization, embedded nuclei and donor cells indicates a consistent change
across the images analyzed, suggesting these parameters of the six may provide a
stronger resolving power to discriminate differences between implant images.

|
Figure 6-7 | Quantitative histomorphometry of images acquired by fluoresce
microscopy. (A) Hierarchical clustering of histomorphometry dataset. Rightmost column
names each of the 106 images classified according to the similarity of the six analyzed
metrics listed on the y-axis. (B) Example image of embedded nuclei classified according
the analysis herein. (C) Comparison of the area fraction of embedded nuclei between
groups. (D) Example image of a region containing donor cells overlying the green
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mineralization label, presented with the classification output as a red overlay in the
bottom image. (E) Comparison of the area fraction of mineralization sites between the
two groups.

Figure 6-8 | Representative images from (A) group α (good bone formation) and (B)
group δ (poor bone formation) from hierarchical clustering. Composite image of
donor cells (cyan), calcein mineralization label (green), hoescht-labeled nuclei (red), and
DIC channel (gray). Scale bars are 200 µm.

When the area fraction of embedded nuclei was compared between each experimental
group, the 1:1 samples had the highest mean value, followed by the N and 1:1 group. The
1:1 group had a significantly higher fraction of embedded nuclei than the 1:5 group.
While close to reaching significance (p=0.0702) at the 95% confidence level, the mean
area fraction of embedded nuclei was not significantly different here between the 1:1 and
N groups. Comparing the area fraction of mineralization sites, the same trend was
observed; the highest mean value was found for the 1:1 group followed by the N and 1:5
groups, respectively. The histomorphometry results suggest that the 1:1 group performed
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better than the 1:5 group, however the difference between samples with and without
beads was not statistically significant here.

Figure 6-9 | Comparison of scaffold mineralization of current experiment to
historical data. (A) Representative fluorescence micrograph showing donor cells (red),
calcein mineralization label (green), and DIC channel (gray) of scaffold with a
permeability of ~10-12 m4/Ns following three weeks of implantation in a calvarial defect.
(B) Representative fluorescence micrograph showing donor cells (cyan), calcein
mineralization label (green), hoescht-labeled nuclei (red), and DIC channel (gray) of
scaffold with a permeability of ~10-9 m4/Ns following three weeks of implantation in a
calvarial defect. All scale bars are 500 µm. (C) Comparison of the area fraction of
mineralization sites between the low and high permeability scaffolds.

To help understand the experiment motivating this work, wherein bone formation was
more limited and to evaluate a larger difference in scaffold permeability, we compared
the area fraction of mineralization sites of samples examined here (Fig. 6-9B) to the
historical dataset (Fig. 6-9A). The scaffolds used here have a mean permeability on the
order of 10-9 m4/Ns, resulting in a 1,000-fold increase when compared to those previously
tested (~ 10-12 m4/Ns). When the area fraction of mineralization sites was compared, a
significant increase in active mineralization sites was observed for the current experiment
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(Fig. 6-9C), further suggesting that a permeability of 10-12 m4/Ns is likely too low for
optimal bone formation for this class of biomaterials.

6.4 Discussion
We wondered if (i) poor scaffold permeability led to suboptimal bone formation in a
previous experiment, (ii) if the permeability of collagen-HA scaffolds could be enhanced
via a nontoxic method, and (iii) if such a permeability enhancement would improve bone
formation in vivo. The outcome of the experiment provides evidence to suggest that poor
permeability is likely the cause of suboptimal bone formation observed previously (Fig.
6-9). Furthermore, we have shown that it is possible to increase the permeability of
collagen-HA scaffolds with a nontoxic gelatin microbead porogen (Fig. 6-1). Increasing
the bead loading from a 1:1 to 1:5 ratio of collagen-HA solids to gelatin porogen did not
significantly increase scaffold permeability. When collagen-HA scaffolds of different
permeability were compared, the quantitative analysis radiographic images suggest that
the 1:1 bead loaded group performed better than the N group without beads (Fig. 6-3).
However, the 1:5 and N group were not significantly different from each other here. This
may be due to the small number of animals examined per group. Alternatively, it is
tempting to speculate that the higher bead loading in the 1:5 group led to a mechanically
weaker scaffold that compressed under the skin after implantation, reducing the effective
scaffold permeability. Further in vivo testing should be undertaken to evaluate collagenHA scaffold permeability above 10-9 m4/Ns and to define the optimal range of scaffold
permeability for the type of bony defect. For instance, Mitsak et al. observed an
improvement in the in vivo performance of PCL scaffolds seeded with BMP-7 transduced
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human fibroblasts with a permeability of 7×10-8 m4/Ns versus 4×10-7 m4/Ns (5.8-fold
difference) when implanted subcutaneously in a mouse model.196 Additionally, the
scaffold cylinder used by Mitsak et al. was approximately 3.6-fold larger by volume than
evaluated here, which provides a larger range for evaluating cell invasion and bone
infiltration. O’Brien et al., found the permeability of lyophilized collagen-GAG scaffold
to be on the order of 10-11 to 10-10 m4/Ns.209 Similarly, we observed good bone formation
in vivo in a calvarial defect model using collagen-HA scaffolds with permeability on the
order of 10-10 m4/Ns combined with culture expanded mouse bone marrow cells, although
these scaffolds were relatively thin (~300 microns).182 We also found the permeability of
the collagen-HA scaffold Healos® to be ~10-8 m4/Ns and have observed good bone
formation in vivo using this material.182 By contrast, collagen-HA scaffolds with a
permeability of ~10-12 m4/Ns led to limited cell invasion and modest bone formation
restricted to the scaffold perimeter (Fig. 6-9A). Grimm and Williams found the
permeability of trabecular bone to be on the order of 10-10 to 10-9 m2 (10-7 to 10-6
m4/Ns).210 The permeability of human trabecular bone serves as a useful reference,
although may not be the definitive optimum for tissue engineering scaffolds. Pannella et
al. have recommended standardization among permeability measurements and provide a
useful table of permeability values for different scaffold materials and measurement
techniques.211 Determination of the maximum collagen-HA scaffold permeability for
bone formation in vivo should help define the optimal scaffold design for cell-based bone
tissue engineering.
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Image processing provides a relatively quick and high throughput method to compare the
performance of cells and biomaterials in vivo. A direct measurement of new bone
formation would be useful when comparing the performance of collagen-HA scaffolds.
However this is difficult in practice because the biomimetic collagen-HA scaffold
sometimes appears similar to bone. The two metrics used here, embedded nuclei and
colocalization of donor cells to mineralization label (Fig. 6-7B and 6-7D), provide a
useful means to characterize new bone formation following a rule-based methodology
despite this difficulty. In the future, collagen-HA scaffolds could be fluorescently stained
prior to the experiment so that any scaffold could be easily distinguished from new bone.
This approach might be particularly useful in a longer-term scaffold degradation study.

Bone tissue engineering scaffolds are often described by morphological parameters such
as porosity, pore size, and interconnectivity. Various efforts have been made to describe
the optimal scaffold design based on morphological parameters. Permeability is a
physical property of a material that can be used to theoretically model the mass transport
within a porous medium. In effect, permeability encapsulates the combined influence of
interconnectivity, pore size, porosity, tortuosity, and anisotropy on the mass transport
within a porous material. The results of this experiment help to delineate the values of
collagen-HA scaffold permeability that will result in success or failure in vivo. We have
also demonstrated the use of a nontoxic porogen to improve the permeability of
lyophilized collagen-HA scaffolds. Identification of the parameters that most strongly
influence in vivo performance and can be identified prior to implantation will improve the
efficacy and consistency of bone tissue engineering scaffolds.
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6.5 Conclusion
Motivated by the suboptimal in vivo performance of a batch of collagen-HA scaffolds,
the relationship between collagen-HA scaffold permeability and bone formation in vivo
was investigated. Three types of scaffolds were fabricated; two scaffolds fabricated using
a sacrificial gelatin bead porogen (k=9.16±2.01×10-9 and 8.8±1.59×10-9 m4/Ns) and one
scaffold without porogen (k=2.17±1.63×10-9 m4/Ns). The 1:1 bead-porogen implants had
a significantly greater mean radiopacity compared to the normal (N) group following
three weeks of implantation in a critical-size calvarial defect model. Quantitative
histomorphometry showed higher mean embedded nuclei and active mineralization sites
for the 1:1 versus N group, however this was not statistically significant here. Taken
together the x-ray and histomorphometry data suggest a 1:1 ratio of collagen-HA solids
to porogen, corresponding to a 4-fold increase in permeability, may improve early (<3
weeks) bone formation in vivo. Comparing the histomorphometry and permeability data
herein to the prior experiment motivating this work, bone formation was significantly
improved when scaffold permeability was ~10-9 rather than ~10-12 m4/Ns. This result
provides evidence that low permeability is a likely mechanism behind modest bone
formation in the prior study. Furthermore, we have demonstrated the use of a nontoxic
method for improving the permeability of lyophilized collagen-HA scaffolds.
Permeability is a mass transport parameter that effectively encapsulates morphological
parameters such as porosity, pore size, and interconnectivity; and correlates with bone
formation in vivo. Furthermore, the measurement of scaffold permeability before
implantation in vivo can be a critical quality control parameter to ensure consistent and
effective bone formation with lyophilized scaffolds and osteoprogenitor cells.
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7 Conclusions and Future Work

7.1 Conclusions
7.1.1

Development of a live animal imaging platform

Tissue-engineering therapies have shown early success in the clinic, however, the cell–
biomaterial interactions that result in successful outcomes are not yet well understood and
are difficult to observe. Here we describe a method for visualizing bone formation within
a tissue-engineered construct in vivo, at a single-cell resolution, and in situ in three
dimensions using two-photon microscopy. First, two-photon microscopy and histological
perspectives were spatially linked using fluorescent reporters for cells in the skeletal
lineage. In the process, the tissue microenvironment that precedes a repair-focused study
was described. The distribution and organization of type I collagen in the calvarial
microenvironment was also described using its second harmonic signal. Second, this
platform was used to observe in vivo, for the first time, host cells, donor cells, scaffolds,
and new bone formation within cell-seeded constructs in a bone defect. We examined
constructs during bone repair four and six weeks after implantation. New bone formed on
the scaffolds, primarily by donor cells. Host cells formed a new periosteal layer that
covered the implant. Scaffold resorption appeared to be site-specific, where areas near the
top were removed and deeper areas were completely embedded in new mineral.
Visualizing the in vivo progression of the cell and scaffold microenvironment should
contribute to our understanding of tissue-engineered regeneration and lead to the
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development of more streamlined and therapeutically powerful approaches.

7.1.2

Consistent bone formation with collagen-hydroxyapatite scaffolds

Osteoprogenitor cells combined with supportive biomaterials represent a promising
approach to advance the standard of care for bone grafting procedures. However, this
approach faces challenges, including inconsistent bone formation, cell survival in the
implant, and appropriate biomaterial degradation. We have developed a collagenhydroxyapatite (HA) scaffold that supports consistent osteogenesis by donor-derived
osteoprogenitors, and degrades faster than a pure hydroxyapatite scaffold. Herein, the
material properties are characterized as well as cell attachment, viability, and progenitor
distribution in vitro. Furthermore, we examined the biological performance in vivo in a
critical-size mouse calvarial defect. To aid in the evaluation of the in-house collagen–HA
scaffold, the in vivo performance was compared with a commercial collagen–HA scaffold
(Healo®, Depuy). The in-house collagen–HA scaffold supported consistent bone
formation by predominantly donor-derived osteoblasts, nearly completely filling a 3.5
mm calvarial defect with bone in all samples (n=5) after three weeks of implantation. In
terms of bone formation and donor cell retention at three weeks post implantation, no
statistical difference was found between the in-house and commercial scaffold following
quantitative histomorphometry. The collagen–HA scaffold presented here is an open and
well-defined platform that supports robust bone formation and should facilitate the
further development of collagen–hydroxyapatite biomaterials for bone tissue engineering.
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7.1.3

Optimizing cell delivery to calvarial defects

Cell-based tissue engineering can be used to replace missing or damaged bone, but the
optimal methods for delivering therapeutic cells to a bony defect have not yet been
established. Using transgenic reporter cells as a donor source, two different collagenhydroxyapatite scaffolds, and a critical-size calvarial defect model, we investigated the
effect of a cell-attachment period prior to implantation, with or without an extracellular
matrix-based seeding suspension, on cell engraftment and osteogenesis. When
quantitatively compared, the in-house scaffold implanted immediately had a higher mean
radiopacity than in-house scaffolds incubated overnight. Both scaffold types implanted
immediately had significantly higher area fractions of donor cells, while the in-house
collagen scaffolds implanted immediately had higher area fractions of the mineralization
label compared with groups incubated overnight. When the cell loading was compared in
vitro for each delivery method using the in-house scaffold, immediate loading led to
higher numbers of delivered cells. Immediate loading may be preferable in order to avoid
cell loss during overnight incubation. The use of a secondary ECM carrier improved the
distribution of donor cells only when a pre-attachment period was applied. These results
improve our understanding of cell delivery to bony defects in the context of in vivo
outcomes.

7.1.4

Examining the permeability of collagen-hydroxyapatite scaffolds

Bone tissue engineering using biomaterial scaffolds and culture-expanded
osteoprogenitor cells has been demonstrated in several studies, however is not yet a
clinical reality. One challenge is the optimal design of scaffolds for cell delivery, and the
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identification of scaffold parameters that can delineate success and failure in vivo.
Motivated by a previous experiment in which a batch of lyophilized collagen-HA
scaffolds displayed modest bone formation in vivo, despite having large pores and high
porosity, we began to investigate the effect of scaffold permeability on bone formation.
Herein we fabricated scaffolds with a permeability of 2.17±1.63×10-9 m4/Ns and 4-fold
higher using a sacrificial gelatin porogen at a 1:1 and 1:5 weight ratio of solids to
porogen. Scaffolds were seeded with mouse bone marrow stromal cells carrying a
fluorescent reporter for osteoblast differentiation and implanted into critical-size calvarial
defects in immunodeficient mice. Following euthanization three weeks later, bone
formation was present in all implants. The porogen scaffold group containing a 1:1 ratio
of solids to beads was significantly more radiopaque than the scaffold group without the
bead porogen. Quantitative histomorphometry uncovered the same trend between the 1:1
group and scaffolds without the bead porogen found in the radiographic data, however
this was not statistically significant here. Taken together, the x-ray and histology suggest
that the 1:1 ratio of porogen to scaffold solids, resulting in a 4-fold increase in
permeability, may enhance bone formation when compared to scaffolds without porogen.
Interestingly, the 1:5 group did not perform as well as the 1:1 group. When the same
histomorphometry analysis was applied to the experiment motivating this work, scaffolds
with a permeability of ~10-9 m4/Ns compared with ~10-12 m4/Ns proved to form
significantly more bone after 3 weeks in vivo. Scaffold permeability can be a useful
quality control measure prior to implantation and this practice should improve the
consistency and efficacy of cell-based bone tissue engineering.
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7.2 Future work
7.2.1

Extending the limit of 2-photon imaging depth

This work found a maximum imaging depth of roughly 200 µm in calvarial bone using 2photon microscopy. Imaging depth by 2-photon microscopy has been increased by others
following two different approaches; tissue clearing212 and serial 2-photon tomography213.
I have evaluated both of these methods with promising results. Simply put, imaging depth
is limited in 2-photon microscopy by light scattering. Tissue clearing is a method that
reduces the scattering in tissues by replacing the water (refractive index of 1.33) found
within the tissue with a liquid of a similar refractive index to the proteins (~1.5) that
make up most of the tissue. Treatment of a calvarium with a 1:2 solution of benzyl
alcohol and benzyl benzoate (BABB)212 yielded transparent bone (Fig. 7-1A), and
enabled second harmonic imaging completely through a mouse calvaria (Fig. 7-1B).
However this method proved incompatible with transgenic reporters due to degradation
of the GFP signal in BABB. By contrast, treatment of calvaria with ClearT2214 (1:1 (40%
PEG 8000 in water):(99% Formamide)), enabled deeper imaging in calvarial bone and
retained a strong GFP signal (Fig. 7-1C). Alternatively, tissue samples of an arbitrarily
large size can be serially imaged by 2-photon microscopy and later reconstructed.213 A
decalcified long bone of a triple transgenic mouse (OC-YFP, COL1A1-CFP, COL10mCherry) was imaged by TissueVision, Inc (Cambridge, MA) and reconstructed in three
dimensions (Fig. 7-1F and 7-1G). Large-scale three-dimensional reconstructions of bone
repairs containing fluorescent reporters should provide researchers with a new
perspective and lead to new observations. One example is when Dr. Achint Utreja and I
imaged the curved surface of the condyle and reconstructed the tissue in three
dimensions; a unique pattern of gene expression was found that could be only appreciated
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from this perspective (Fig. 7-1E). Tissue clearing, serial 2-photon tomography, and farred dyes (longer wavelength light is scattered less) should enable large-scale threedimensional reconstructions of biological samples. Automated image acquisition and new
image processing algorithms, when applied to large-scale three-dimensional datasets,
should deepen our understanding of bone biology, repair, and bone tissue engineering.

Figure 7-1 | Extending the reach of 2-photon microscopy. (A) Mouse calvarium
cleared with BABB. Scale bar is 2 mm (B) Side view of 3D reconstruction of BABB
cleared calvarium, viewed along the suture line. Second harmonic signal (blue) and
col2.3eGFP signal (green). Scale bar is 200 µm. (C) Top view of (B). Scale bar is 200 µm.
(D) Side view of 3D reconstruction of ClearT2 cleared calvarium, showing cross section
of parietal lobe. Scale bar is 200 µm. (E) Top view of (D) showing col2.3eGFP
osteocytes (green) and second harmonic (blue). Scale bar is 100 µm (F) Single slice of
mouse long bone imaged by serial 2-photon tomography. (OC-YFP, COL1A1-CFP,
COL10-mCherry, cutoff filters used: Red-(560nm)-Green-(500 nm)-Blue. Scale bar is
500 µm (G) Large-scale 3D reconstruction of mouse long bone picture in (F) using serial
2-photon tomography. Scale bar is 1 mm. (H) Top view of mouse condylar cartilage.
Scale bar is 200 µm.
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7.2.2

Optimization of scaffold permeability for bone formation in vivo

Scaffold permeability can be an important factor influencing bone formation in vivo and
should be used as a quality control parameter to ensure successful outcomes. Further
optimization of the fabrication process along with more sensitive permeability
measurements will help to ensure scaffolds are produced consistently and with the
desired physical properties. Since different bone defects may require scaffolds with a
different permeability, or a permeability gradient within the bulk material, further work
on control and optimization of scaffold permeability in the context of in vivo outcomes
should prove useful. Pannella et al. discuss the different methods that can be used to
measure permeability and calls for standardization among measurement practices. Only
when the scaffold structure is optimized and a rigorous quality control process in place
can additional modifications (such as growth factor addition) be confidently examined in
experiments with greater statistical power (>10 animals per group).

7.2.3

Evaluation of long term functional properties of tissue engineered bone

The relatively short time scale of healing evaluated here (~ 3 weeks) can provide a rapid
assessment of scaffold performance. Building on lessons learned in the short-term model,
a long-term model evaluating the functional properties of new bone by mechanical testing
is required in the future to define the quality of the regenerated bone. I have examined the
performance of the Col-HA scaffolds in a long bone model of bone repair after eight
weeks of implantation as a preliminary experiment in two animals (Fig. 7-2). An increase
in radiopacity was observed over the eight-week implantation period, suggesting scaffold
mineralization. These results suggest the Col-HA scaffolds are capable of bridging
murine long bone defects, however mechanical testing is need to evaluate how well the
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repaired bone is to an untreated control and/or an autologous bone. This data would
provide a detailed progress report on the success of a cell-based approach compared with
other methods and provide required preliminary data for the larger animal models needed
before scaling up to human bone.

Figure 7-2 | Radiographic progression of two long bone defects filled with collagenHA scaffolds and culture expanded BMSCs.

7.2.4

Covalent linking of growth factors to collagen-HA scaffolds using fibronectin
fragments

Growth factors such as BMP-2 are potent stimulators of bone formation69, however the
supraphysiological doses required can lead to negative side effects in human
patients.77,199,200 Alternatively, growth factor dose can be reduced by delivering factors
along with synergistic signaling moieties found in the ECM, such as fibronectin
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fragments.29 Furthermore, since type I collagen contains fibronectin binding sites151,
fibronectin fragments could be used to covalently link growth factors to the collagen-HA
scaffold, preventing bolus release upon implantation and leveraging synergistic signaling
between fibronectin and BMP-2. Fibronectin contains binding sites that strongly bind to a
variety of growth factors,185 broadening the possible candidates of factors that could be
delivered. This approach could also be combined with cell-delivery to examine if this
would further lower the growth factor doses required and/or enhance bone formation in
vivo beyond cell or factor delivery alone.

7.3 Closing remarks
Bone tissue engineering promises to improve the quality of life of many patients
suffering from bone injury or injuries that fail to heal. This dissertation has described new
methods and progress towards a more complete understanding of bone tissue engineering
using osteoprogenitor cells. Only with a deep understanding of the cellular and materials
basis underlying the successful healing of bony defects will bone tissue engineering make
clinical advances. Given the tremendous progress that has been made in the past decade
by an ever-growing community of scientists, the future of bone tissue engineering seems
bright.
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